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ABSTRACT 
Background and Purpose: Gallstones affect up to 15% of the U.S. adult 
population. Women are at greater risk for cholelithiasis, especially if they are overweight, 
over forty years of age, or have had children. The Veterans Health Administration (VHA) 
performed 114,653 cholecystectomy surgeries with 107,975 patients diagnosed with 
cholelithiasis from 2008 to 2013. Female veterans may be at even greater risk for 
cholelithiasis. However, research with this vulnerable population is sparse. Therefore, the 
purpose of this study was to examine physiological and environmental risk factors that 
may be associated with cholelithiasis among female veterans. 
Study Design and Theoretical Framework: This retrospective case-control 
study examined the VHA electronic medical data for possible risk factors associated with 
cholelithiasis among female veterans. Wittenburg and Lammert’s model, describing 
factors contributing to cholesterol susceptibility, guided this study examining 
multifactorial influences that may precipitate cholelithiasis in a population of female 
veterans.  
Sample Selection: Data representing samples of ethnically-diverse female 
veterans over 40 years of age were retrospectively randomly selected from the VHA data 
between January, 2008 and December, 2013. Study data were retrieved through the 
Veterans Affairs Informatics and Computing Infrastructure (VINCI) system from 242 
xvi 
patients assigned to each of the study groups based on presence of absence of 
cholelithiasis diagnosis.  
Methods: Demographic, military service, comorbidity, and laboratory test data 
were analyzed for differences between the cholelithiasis and control groups. Data were 
further analyzed using multiple regressions to explore the relationship of risk factors to 
cholelithiasis occurrence.   
Results: Tobacco use was significantly (p< .01) higher in female veterans with 
cholelithiasis than those without cholelithiasis. Also higher serum cholesterol (p < .01) 
and hemoglobin A1c (p< .01) levels were positively associated with female veterans 
experiencing cholelithiasis while lower High-Density Lipoprotein (HDL) blood levels 
were significantly related (p < .01) to cholelithiasis occurrence for the women. The 
women also had higher frequencies (p < .01) of hypertension and hepatitis C than those 
women without cholelithiasis. Results of multiple regression analysis indicated that 
serum cholesterol, hemoglobin A1c, and HDL levels accounted for 26 % of the variance 
for risk in female veterans developing cholelithiasis. Also, the women with a history of 
hypertension and hepatitis C had 2.5 times the risk of developing cholelithiasis than those 
without hypertension and hepatitis C.  
Conclusions and Implications: Tobacco use, higher cholesterol and hemoglobin 
A1c levels, lower HDL levels, and a history of hypertension and hepatitis C were 
associated with increased risk for cholelithiasis occurrence in female military veterans. 
Understanding risk factors associated with cholelithiasis in military female veterans may 
promote patient-centered care and build preventive strategies in this rising but 
understudied population. 
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CHAPTER I 
INTRODUCTION 
 Gallstone disease is one of the most prevalent gastrointestinal diseases and affecting 
approximately 10-15% of the adult population in the United States. Women are at greater risk 
(Barbara et al., 1987), especially if they are overweight (Maclure et al., 1989), over 40 years of 
age (Attili et al., 1997), or had children (Attili et al., 1997). Further, cholelithiasis increases the 
risk of gallbladder and colorectal cancer (Schernhammer et al., 2003; Siddiqui et al., 2009), 
especially in women. Between 2008 and 2013, the Veterans Health Administration performed 
114,653 cholecystectomy surgeries on 107,975 patients diagnosed with cholelithiasis. While 
female veterans comprised 14% (2,677) of all cholecystectomy procedures (19,801) in 2011 at 
the VHA, only 6% of the 514,500 total population enrolled in the VHA database were women 
during that same year (VHA, 2014). Therefore, female veterans may be at even greater risk for 
cholelithiasis and cholecystectomies. However, research with this vulnerable population was not 
found. Furthermore, environmental and occupational risks experienced by these women who 
have served their country may only further complicate their risks for gallstones. Therefore, the 
purpose of this study was to examine physiological and environmental risk factors that may be 
associated with the occurrence of cholelithiasis among female veterans. 
Statement of the Problem 
Gallstones affect approximately 10-15% of the adult population in the United States and 
prevalence is rising. Annually, it is estimated that one million patients are newly diagnosed with 
2 
cholelithiasis with 1.8 million ambulatory care visits and costing approximately 6.5 billion 
dollars (Everhart, Khare, Hill, & Maurer, 1999; Shaheen et al., 2006). This trend has increased 
by greater than 20% over the last three decades, making gallstone disease a leading cause for 
gastrointestinal hospital admissions (Everhart & Ruhl, 2009; Sandler et al., 2002; Shaffer, 2005).  
Although most cholelithiasis (the formation of gallstones) is asymptomatic (Gracie & 
Ransohoff, 1982), 25-50% of asymptomatic patients eventually develop symptoms and 
complications (Beckingham, 2001; Gracie & Ransohoff, 1982) that result in a cholecystectomy 
(removal of gallbladder), the standard care for symptomatic cholelithiasis or in endoscopic 
retrograde cholangio pancreatography (diagnostic purpose or allowing bile to drain). Many 
studies have indicated that cholecystectomy surgeries are not benign procedures, although it is 
one of the most common surgeries in the United States. Approximately 20-40% of patients 
developed post cholecystectomy syndrome
 
(Yamada, 2013), and complications have been 
observed in almost 20% of laparoscopic cholecystectomies performed on older adults (Pérez et 
al., 2006). Many researchers have also been concerned about the causal relationship between 
cholecystectomy procedures and colon cancer occurrences (Schernhammer et al., 2003; Siddiqui 
et al., 2009). However, more knowledge of epidemiological characteristics of gallstone 
formation is greatly needed to better identify preventive strategies. 
 Cholecystectomies are one of the most frequent surgeries of the Veterans Health 
Administration (VHA) and symptomatic cholelithiasis is one of the criteria to define disability 
claims in the military. However, limited studies have been conducted to identify risk factors for 
cholelithiasis occurrence in the military veteran population. The prevalence of cholelithiasis has 
increased among patients in the Veterans Health Administration (VHA), especially among 
female veterans (VHA, 2014).  
3 
The female veteran population is projected to increase by 12% within the next five years
 
while the male veteran population is projected to decrease by approximately 27% over the same 
period (Women Veteran Profile, 2013). Female veterans are serving prolonged military 
deployments with increasing numbers of women serving in combat. Given their service and 
sacrifice, the health care needs of female veterans are unique and should be appropriately 
addressed. There is a great demand to promote the health status of female veterans while 
decreasing the risks of cholelithiasis or cholecystectomy occurrence by identifying predisposing 
factors for gallbladder diseases.  
Statement of the Purpose 
 The purpose of this study is to explore multidimensional predisposing factors that may be 
associated with developing cholelithiasis among military female veterans. The predisposing 
factors that were collected have been shown in the literature to be associated with cholelithiasis 
and cholecystectomies, included demographical data, occupational/environmental factors, serum 
laboratory tests, and comorbidities. The associations of these independent variables and the 
occurrence of cholelithiasis were examined.  
Study Implications  
A long-term goal of this proposed study was to identify preventive strategies to improve 
the health status of military female veterans and decrease their risk for comorbid conditions. The 
specific aims have been developed to accommodate the purpose of this study.  
Specific Aims 
 In response to the purpose of this study, the following specific aims guided this dissertation 
study:  
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Aim 1. Determine the demographic and environmental characteristics of female military veterans 
with and without cholelithiasis.  
Aim 2. Examine differences among metabolic, liver enzyme and serum lipid laboratory data in 
female military veterans with and without cholelithiasis.  
Aim 3. Explore differences between diagnosed metabolic and biliary comorbidities experienced 
by female military veterans with and without cholelithiasis. 
Aim 4. Explore associations among demographic, environmental, laboratory data and diagnosis 
of comorbid conditions among female military veterans with and without cholelithiasis. 
Operational Definitions 
The following terms and definitions are explained in relation to the current study. 
Table 1. Terms and Definitions for this Study 
 
Concept or Variable 
 
 
Definitions 
 
Cholelithiasis 
 
Cholelithiasis is defined as patients who were diagnosed with 
gallstones using an ultrasound technology and these data were recorded 
in the VHA data using an International Classification of Diseases, 
Ninth Revision (ICD-9) code of cholelithiasis. 
 
Symptomatic 
Cholelithiasis 
Symptomatic cholelithiasis is defined as a condition when the patient 
claimed any pain or discomfort related to cholelithiasis, which, in turn, 
results in a cholecystectomy.  
 
Female Veterans Female veterans refer to women who have served on active duty in the 
US Army, Navy, Air Force, Marine Corps, or the Coast Guard but not 
currently serving on active duty. For this study, female veterans are 
those who have established veteran status and were approved for 
eligibility in using the US Veterans Health Administration (VHA).  
 
The VHA Enrolled 
Female veterans  
Military female veterans refers to women who were approved to 
receive medical benefits and have used services from the VHA, such as 
a routine check-up, emergency services, inpatient and outpatient care, 
pharmacy, radiology, and laboratory services. This study included 
5 
female veterans who were seen in the VHA from January 1, 2008 to 
December 31, 2013. 
 
The VINCI Data 
 
The Veterans Affairs’ (VA) Informatics and Computing Infrastructure 
(VINCI) was created to support research, clinical decision, and 
business benefits of the US Veterans Health Administration.  The 
VINCI is an effective tool to facilitate researchers’ access to the VHA 
data while ensuring veterans’ privacy and confidentiality. The VINCI 
workspace is a secure, virtual environment that provides resources and 
tools necessary to conduct studies and analyze data. Additional data 
requests, data storage, backup, consulting service, statistic tools and 
data manage software are provided through the VINCI system. 
 
 
Significance of the Study 
Although a significant number of studies have attempted to uncover the risk factors for 
cholelithiasis and gallstone formation, they still remain unclear. Most studies have sought to 
identify the association between individual risk factors, such as lipids profile, diet, ethnicity, 
disease, and drugs, and the occurrence of cholelithiasis. Only a few studies use a 
multidimensional approach and take into account numerous risk factors related to the occurrence 
of cholelithiasis. Limited data demands the identification of multifactorial causes of gallstone 
formation based on military female veterans. 
 The contribution of this study was to identify predisposing factors of cholelithiasis in 
female veterans in an effort to identify preventive measures for the disease. Study outcomes may 
also provide nurses a greater understanding for cholelithiasis and also present guidance for 
patients diagnosed with gallstones. Using existing data decreases bias that participants might 
create, and grants a logical, systemic, and cost effective approach to identify the possible 
association with cholelithiasis among diversely located female veterans. The electronic medical 
record of the Veterans Health Administration (VHA) is linked with the VHA administrative data, 
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which is known to have a high level of data element completion and accuracy (Kashner, 1998; 
Singh, 2009). Moreover, the study data was retrieved from actual electronic medical records of 
the Veterans Health Administration system (VHA) and may reflect a subset of female veterans in 
the VHA system. Finally, this study included a nationwide random sample with diverse 
individuals’ medical and surgical histories, thus decreasing selection biases. 
Theoretical Framework 
 The theoretical framework for this study is adapted from Wittenburg and Lammert’s 
(2007) Factors Contributing to Cholesterol Gallstone Susceptibility, which is well suited for 
understanding gallstone occurrence. The physiological model describes that gallstone formation 
is due to multifactorial influences. Gallstone disease is identified not by a single gene 
contribution but as a result of combining factors with the geographical and ethnic differences, a 
complex genetic predisposition, and their interaction with multiple environmental factors that 
determine the risk for developing gallstones. This physiological model supports the premise that 
gallstone formation is multifactorial. Associational factors should also be considered for 
cholelithiasis occurrence when multiple environmental risk factors surround the patients.  
Assumptions 
 Although multiple logistic regressions do not make assumptions of normality, linearity, 
or homoscedasticity for the independent variables as linear regression does, the following 
assumptions may apply for logistic regression.    
 First, the dependent variable should maintain independence among the dependent 
variables. The current study met this assumption since the outcomes were dichotomous, 1) with 
cholelithiasis or 2) without cholelithiasis.  
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 Second, the dependent variable should be classified using dummy coding that “1” is the 
probability of the event occurring and “0” is the probability of the event not occurring. The 
dependent variables in this study were coded that “1” with cholelithiasis and “0” without 
cholelithiasis. 
 Third, the model should be fitted correctly. The current study used a stepwise method to 
select only significant variables to maximize the productiveness of the model. Moreover, the 
Hosmer-Lemeshow test and Chi-square goodness of fit test in SPSS was used to measure how 
well the logistic model fit the study data.   
 Fourth, independent variables should be independent from each other. This study used 
stepwise regression method to demonstrate significant contributing factors associated with 
cholelithiasis occurrence in female veterans while accounting confounding effects of variables.  
 Finally, multiple logistic regressions require a larger sample size than linear regressions 
because maximum likelihood coefficients are less powerful than ordinary least squares in case 
the smaller sample sizes are used. The sample size should be at least 5-10 cases for each 
independent variable (Field, 2005). This study accepted over five samples for each independent 
variable.  
Limitations and Delimitations 
This study had several limitations: 
Study Design 
 The major limitation of a case-control study is risk (incidence of cholelithiasis) cannot 
be established directly (Hogue, Gaylor, & Schulz, 1983). Relative risk can only be estimated and 
cannot be used to draw inferences about the causal relationships between and among the 
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variables (Hogue, Gaylor, & Schulz, 1983). Retrospective studies may be more apt to selection 
bias.  
 Systematic bias could be present if there was a systemic error in how subjects were 
selected as cases and controls. Systemic bias includes selection bias and information bias. First, 
increasing the sample size cannot reduce selection bias (Pannucci & Wilkins, 2010). Ideally, 
drawing homogenous samples should decrease selection bias. For this study, the sample of the 
study population was drawn from the same database in the Veterans Health Administration and 
the same population among military female veterans. The case and control groups were planned 
to be as comparable as possible in all aspects except having cholelithiasis or not.  
 Second, a possible inadvertent collection of erroneous data could contribute to 
information bias due to invalid or imprecise study measurement. Patient medical records could 
contain incomplete and/or inaccurate data depending on the record keeping practices of the 
medical institutions, resulting in ascertainment bias. However, for this study, the study groups 
were selected using an ICD code of cholelithiasis, ensuring that the diagnosis was confirmed 
with an ultrasound (sensitivity 0.97; 95% CI, 0.95–0.99, specificity 0.95; 95% CI, 0.88–1.00) 
(Shea et al., 1994), and recorded as a patient’s diagnosis within the Veterans Health 
Administration system. Both groups met the inclusion/exclusion criteria to reduce potential 
misclassification and to maximize the validity of the study.  
 Finally, hospital-based bias could impact the analysis of potentially confounding 
variables. In other words, it was hard to determine whether the exposure and cholelithiasis 
occurrence may be associated with another disease. In this study, controls were selected 
randomly from existing data while meeting study eligibility. The collection period for clinical 
record was set from January 1 of 2008 to December 31 of 2013 to reduce the chance for 
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Berkson’s bias. Recall bias, interview bias, and response bias were avoided because of using 
retrospective medical records based study plan.  
Statistical Analyses 
The major strengths of this study are the statistical power and statistical methods used. A 
case-control is a type of study that allows for relative ease of large sample recruitment (Pedhazur 
& Schmelkin, 1991; Stevens, 2002), and thereby providing sufficient power for the study. One 
potential limitation of the study was that it might be difficult to control for Type I error 
simultaneously with the utilization of a multiple unadjusted Odds Ratio. This may increase the 
rate of false positive findings. Multiple regression methods were used to address confounding 
and produce adjusted odds ratio.  
 Another potential limitation of multiple regression study is multicollinearity (Slinker & 
Glantz, 1985; Tu, Clerehugh, Gilthorpe, 2004) that might make it difficult to identify the change 
in the dependent variable precisely to one or the other of the independent variables, and may 
increase Type II errors. Matching the two groups was minimized in this study because 
investigation of risk factors could be hard if case and controls were matched on a causing factor. 
In addition, the correlation matrix and independent t-test were performed to check for 
multicollinearity by the correlation coefficient between two independent variables. 
Data Source  
 A retrospective study involves the analysis of existing data that has been recorded for 
clinical reasons other than research
 
(Hess, 2004; Tang, 1996). A limitation of retrospective study 
is that data is collected exclusively from past records and does not follow patients, as is the case 
with a prospective study. Errors due to confounding and bias are more common in retrospective 
studies than in prospective studies; however, the methodologies of prospective and retrospective 
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cohort studies are fundamentally the same. For this study, cases and controls were followed up in 
the ensuing time period and the starting point of this study was the same as for all cohort studies. 
For this study, a retrospective study is particularly beneficial to examine possible risk and 
protection variables in relation to a result that is already established at the start of the study.   
Protection of Human Subjects 
 Study approval was sought from the Institutional Review Board of both the Veterans 
Health Administration (VHA) in Orlando, Florida and the University of North Dakota. The VHA 
research committee considered this study as “expedited” because no patient contact or 
identifiable patient information was required. The Institutional Review Board (IRB) of the 
Veterans Health Administration requested that the principal investigator obtain course 
certifications that involved the patients’ privacy, confidentiality, and human protection in 
research to highlight the importance of human rights and human rights’ protection in relation to 
the general research.  
The IRB of the University of North Dakota considered this study as “exempted” due to the 
characteristics of a retrospective study with de-identifiable data use.  
 This study identified risk factors for cholelithiasis among female veterans. Therefore, the 
study population was limited only to female veterans who were enrolled with the Veterans 
Health Administration from January 1, 2008 to December 31, 2013. Males and children were 
excluded from the study consideration because they were not related to the study purpose. All 
data was de-identified and study data were monitored by the data security services in the 
Veterans Health Administration.  
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Summary 
Cholelithiasis is one of the most common but costly digestive diseases affecting 10-15% 
of the adult population in the United States (Barbara et al., 1987). Women are at greater risk.  
The Veterans Health Administration data also showed a similar phenomenon of higher 
cholecystectomy procedure rates in military female veterans in comparison to male veterans. 
Studies focusing on this vulnerable population and the association with cholelithiasis were not 
identified in the literature. Therefore, the purpose of this study was to examine physiological and 
environmental predisposing factors that may be associated with the occurrence of cholelithiasis 
and cholecystectomy.  Information based upon the study outcomes can be used to assist nurses 
who provide resources, and education for patients diagnosed with gallstones. Additionally, the 
findings can be used to promote the health status of female veterans while decreasing the risks of 
cholelithiasis or cholecystectomy occurrence by identifying predisposing factors for gallstone 
disease.   
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CHAPTER II  
REVIEW OF LITERATURE 
The overall objective of this study was to identify possible physiological and 
environmental risk factors associated with occurrence of cholelithiasis among U.S. military 
female veterans. Chapter II presents a review of the literature discussing predisposing factors of 
cholelithiasis occurrence for the current study. This study planned to examine the following 
study aims:  
1)  Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis.  
2)  Examine differences among metabolic, liver enzyme and serum lipid laboratory data 
in female military veterans with and without cholelithiasis.  
3)  Explore differences between diagnosed metabolic and biliary comorbidities 
experienced by female military veterans with and without cholelithiasis.  
4)  Explore associations among demographic, environmental, laboratory data and 
diagnosis of comorbid conditions among female military veterans with and without 
cholelithiasis.  
 Literature reviewed in this chapter was accessed via online databases including PubMed, 
CINAHL, Cochrane, SCOPUS, Academic Search Premier and print editions of peer-reviewed 
research-based journals. Key search terms used were cholelithiasis (or gallstones) and risk 
factors (age, gender, ethnicity, diet, obesity, cholesterol, comorbidities, posttraumatic stress 
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disorder, liver enzymes, etc.) and female veterans and women. 
 Gallstone disease, cholelithiasis, affects over 6 million men and 14 million women 
(Everhart, Khare, Hill, & Maurer, 1999) in the United States (Schirmer, Winters & Edlich, 2005; 
Shaffer, 2005; Tazuma, 2006). It has been recognized as the second most common 
gastrointestinal discharge diagnosis in U.S. hospitalizations (Peery et al., 2012). Further, there 
are almost 3,000 gallbladder related deaths reported in the U.S. annually (Everhart & Ruhl, 2009; 
NIH, 2005). Although cholelithiasis has been one of the most common and costly 
gastrointestinal disorders, the causes and effects in association with gallstone diseases are not 
completely understood (Sanders & Kingsnorth, 2007).     
 The literature review in this chapter includes several topics as background for the current 
study. Topics included are physiology and characteristics of cholelithiasis, risk factors for 
gallstone disease, and causes and effects of health with gallstone disease. The section of risk 
factors is divided into demographic, environmental, pathophysiologic, and comorbidities risk 
factors. Additionally, the gaps in the literature are identified and discussed following each risk 
factor. The theoretical framework by Wittenburg and Lammert (2007), “Factors Contributing to 
Cholesterol Gallstone Susceptibility” is explained because this physiological framework was 
used to guide this study.  
The Physiology and Characteristics of Cholelithiasis 
Cholelithiasis is stones formed in the gallbladder (Venes, 2013). Although the majority of 
gallstones are asymptomatic, up to 25% of gallstones cause symptomatic symptoms or severe 
complications (Freedman, 1993; Halldestam et al., 2004) that include sudden, severe right upper 
quadrant pain, nausea, vomiting, infection, perforation, or gangrene (Gracie & Ransohoff, 1982). 
The most common ways to manage symptomatic gallstone diseases are known to be 
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cholecystectomy and endoscopic or medical treatment of complications. Gallstone size can range 
from < 1 mm to > 3cm in size (Lowenfels, Walker, Althaus, Townsend, & Domellof, 1989). 
Depending on the components of the stone, gallstones can be characterized as cholesterol 
gallstones, brown-colored gallstones, and black pigment gallstones. This study focuses on 
cholesterol gallstones because it is the most common type in the U.S. The other types of 
gallstones are most likely related to certain ethnic groups and underlying comorbidities (Sherlock 
& Dooley, 2002; Vitek & Carey, 2003; Kodaka, Sono, Nakagawa, Kakino, & Mori, 2004).  
Risk Factors for Gallstone Disease 
Gallstone formation is a complex interaction of genetic, environmental, metabolic, and 
related conditions. Traditionally, the four “F’s”—female, fat, forty and fertile—are considered as 
risk factors for gallstone diseases (Sherlock, 1963). Being overweight, a sedentary lifestyle, and 
processed food are contributing factors for cholesterol gallstones (Shaffer, 2006; Tsai et al., 
2004a). Cholesterol gallstones have found to be influenced by predisposing factors including 
female gender, advanced age, ethnicity, a Westernized diet, obesity (Di Ciaula, Wang, Wang, 
Leonilde & Portincasa, 2010), and certain comorbidities (Andreotti et al., 2008; Atamanalp et al., 
2013; Carey & Paigen, 2002; Di Ciaula et al., 2010; Portincasa, Moschetta, & Palasciano, 2006; 
Venneman & Van Erpecum, 2010). Causes of risk factors have not been completely established 
although cholelithiasis is one of the most common and costly gastrointestinal disorders to treat 
(Sanders & Kingsnorth, 2007).  
Demographic Risk Factors 
Age and gallstones. The prevalence of gallstones increases with age in all racial and 
ethnic groups. Studies show people age 40 years and older are ten times more likely to develop 
gallstones (Chen et al., 1998, Einarsson, Nilsell, Leijd, & Angelin, 1985; Festi et al., 2008; 
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Shaffer, 2005; Volzke et al., 2005). The declined activity of the limiting enzyme, 7α-
hydroxylase, is a contributing factor as the aging individual experiences cholesterol saturation 
and decreasing mobility of the gallbladder emptying (Carulli et al., 1980; Salen, Nicolau, Shefer 
& Mosbach, 1975). Female veterans over 40 years of age consist of approximately 60% of the 
entire female veteran population with a median age of female veterans of 49 (Women Veteran 
Profile, 2013). Thus, the sample for the dissertation study composed of female veterans over 40 
years of age.  
Gender and gallstones. Women have a higher risk of cholelithiasis than men at all ages 
(Everhart et al., 1999; Everhart et al., 2002; Racine et al., 2013; Singh, Trikha, Nain, Singh & 
Bose, 2001). This may be attributed to the fact that female sex hormones, specifically estrogen, 
may account for gender difference in gallstone formation (Attili et al., 1997; Cirillo et al., 2005). 
Many studies have demonstrated women having a greater chance of developing gallstones and 
also of undergoing cholecystectomy procedures in comparison to men of all age groups (Chen et 
al., 1998; Everhart et al., 1999; Everhart et al., 2002; Racine et al., 2013; Singh, Trikha, Nain, 
Singh & Bose, 2001).  
 Estrogen appears to play a role for the gender difference in gallstone formations (Attili et 
al., 1997; Cirillo et al., 2005). Yet, only a few epidemiologic studies have contributed to findings 
related to gender, with most of these findings focused on the variation of the female hormone, 
estrogen (Cirillo et al., 2005; Hulley et al., 1998). The same phenomenon has been observed 
among patients in the Veterans Health Administration (VHA), especially among female veterans 
(VHA, 2014). Although female veterans who enrolled in the Veterans Health Administration 
(VHA) only consist of approximately 6% (514,500) of the total VHA patient population 
(8,574,198) in 2011 (VetPro 2011), they accounted for 14% (2,677) of all cholecystectomy 
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procedures (19,801) in the same year. This trend has been observed throughout the current 
decade (VHA 2014). This study comprises a nationwide random sample of ethnically diverse 
female veterans with possible physiologic, environmental, and occupational risk factors. 
Ethnicity and gallstones. The risk of gallstone diseases differs by race. Cholelithiasis 
prevalence has been found to be significantly higher in American Pima Indians, especially in the 
female population (Sampliner et al., 1970). A later study reported 46.3% of American Indian 
women underwent a cholecystectomy at some point in their lives (Everhart et al., 2002). Some 
studies found a higher prevalence rate for cholelithiasis in Chile (Covarrubias, Valdivieso, & 
Nervi, 1984) and in the Mexican-American population (Hanis et al., 1993; Maurer et al., 1989). 
Other studies also observed certain indigenous populations, particularly in South America and 
Northern India, have a higher incidence of gallstone disease and gallbladder cancer (Dutta et al., 
2005; Hundal & Shaffer, 2014; Misra, Chaturvedi, Misra & Sharma, 2003; Zatonski et al., 1997).  
 Body weight and gallstones. Obesity is an established contributing factor for gallstone 
formation. Studies have related high body mass index (BMI) to gallstone diseases (Katsika, 
Tuvblad, Einarsson, Lichtensten, & Marschall, 2007; Portincasa et al., 2006; Stender, 
Nordestgaard & Tybjaerg-Hansen, 2013; Volzke et al., 2005). Obese persons have a high ratio of 
cholesterol to solubilizing lipids (bile acids and phospholipids) (Grundy, Duane, Adler, Aron, & 
Metzger, 1974; Grundy, Metzger, & Adler, 1972). The high ratio predisposes to crystallization of 
cholesterol and gallstone formation. In many cases, the amounts of cholesterol entering the bile 
exceed the solubilizing capacity of the bile acids and phospholipids in the obese population 
(Bennion & Grundy, 1975). Longitudinal studies reported a significant association between 
abdominal adiposity and the incidence of symptomatic gallstone disease (Attili et al., 1997; 
Everhart et al., 1999; Tsai et al., 2004a). Another longitudinal study based on the Nurses’ Health 
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Survey supported participants with higher BMI have higher likelihood to undergo 
cholecystectomy surgeries (Stampfer et al., 1992). Morbidly obese women (BMI ≥45 kg/m2) 
were seven times more likely to have symptomatic gallstones compared to leaner women (BMI 
≥30 kg/m2) (Stampfer et al., 1992).  
Environmental Risk Factors  
Alcohol use and gallstones. An association between alcohol consumption and gallstone 
diseases is controversial. Some studies found that moderate alcohol intake lowers gallstone 
development (Leitzmann et al., 2003; Volzke et al., 2005) due to the mechanism by diminishing 
bile cholesterol saturation and enhancing HDL-cholesterol levels (Pixley & Mann, 1988). 
However, other studies have failed to find the same association (Kratzer et al., 1997; Walcher et 
al., 2010).  
Tobacco use and gallstones. Studies examining the association between smoking habits 
and gallstone formation are also questionable. Studies have found that women who smoked 
heavily (more than 35 cigarettes per day) had a high prevalence rate for asymptomatic 
cholelithiasis as well as symptomatic cholelithiasis (Murray, Logan, Hannaford, & Kay, 1994; 
Stampfer et al., 1992). Other studies have failed to find such a relationship between tobacco use 
and gallstone development (Katsika et al., 2007; Shaffer, 2006; Walcher et al., 2010). Park et al. 
(2011) reported that male veterans were more likely to be heavy alcohol drinkers and smokers 
compared to non-veterans, therefore examining these factors in relation to the cholelithiasis 
occurrence among female veterans would provide a unique understanding of this study 
population. 
18 
Pathophysiologic Risk Factors  
Metabolic factors and gallstones. “Westernized nutrition” (Paigen & Carey, 2002; Tsai, 
Leitzmann, Willett & Giovannucci, 2008) is a well-known risk factor for gallstone formation 
(Tsai et al., 2004b; Tsai, Leitzmann, Willett & Giovannucci, 2005b; Tsunoda, Shirai, & 
Hatakeyama, 2004). Results of other studies have shown a positive relationship between 
gallstone disease and dietary risk factors such as high calorie consumption (Tsunoda et al., 
2004), increased dietary glycemic load (Tsai, Leitzmann, Willett, & Giovannucci, 2005a; Tsai, 
Leitzmann, Willett, & Glovannucci, 2005b), refined sugar intakes (Alessandrini, Fusco, Gatti, & 
Rossi, 1982; Misciagna et al., 1999; Moerman, Smeets, & Kromhout, 1994; Scragg, McMichael, 
& Baghurt, 1984), and chronic hyper-nutrition (Al-Azzawi et al., 2007; Biddinger et al., 2008). 
However, some studies show cholesterol gallstone formation associated with dietary factors still 
remain controversial (Andreotti et al., 2008; Halldestam, Kullman & Borch, 2009).  
 Although numerous study authors have focused their work on how dietary factors are 
directly related to the increased prevalence of gallstones (Stinton, Myers, & Shaffer, 2010), the 
actual importance of one’s dietary content is unclear and difficult to analyze (Mendez-Sanchez, 
Zamora-Valdes, Chavez-Tapia, & Uribe, 2007; Tseng, Everhart, & Sandler, 1999). Using the 
advantage of retrospective data, this study examined the relationship between the occurrence of 
gallstone disease and biochemical laboratory values, such as fasting glucose, hemoglobin A1C, 
liver enzymes and lipids profile tests. The serum laboratory tests provided the individuals’ 
indirect diet patterns and made it possible to measure in a more objective way.  
Lipids profile and gallstones. A major component of gallstones is cholesterol. The 
proportion of cholesterol is even more dominant in cholesterol gallstones (Caturelli & Buscarini, 
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1994). Although numerous studies have tried to identify the relationship between serum 
laboratory levels of cholesterol and gallstones, the outcomes are still not clear.   
 Many studies have reported a significant relationship between high serum cholesterol 
levels and an increased risk for cholelithiasis development (Andreotti, Chen et al., 2008; 
Atamanalp, Keles, Atamanalp, Acemoglu, & Laloglu, 2013; Khairy, Guraya, & Murshid, 2004; 
Venneman & Van Erpecum, 2010). Yet, some studies have shown an inverse relationship 
between serum cholesterol levels and gallstone occurrence (Thijs et al. 1990). Further, studies 
have reported a relationship between serum Low Density Lipoprotein (LDL) levels and an 
increased risk for cholesterol gallstone diseases (Fu, Gong, & Shao, 1995; Fu et al., 1997; Han, 
Jiang, Suo, & Zhang, 2000). Although, other studies did not find the same significant 
relationship between serum LDL levels and gallstone risk (Andreotti et al., 2008; Tang, 1996).  
 Correlations have been found between serum High-Density Lipoprotein (HDL) levels and 
gallstone diseases (Andreotti et al., 2008; Fu et al., 1995; Fu et al., 1997; Halldestam, 2009; 
Tang, 1996; Thijs et al., 1990). Some studies have reported low HDL levels were highly 
associated with gallstone risks (Andreotti et al., 2008; Fu et al., 1995) while other studies failed 
to find the same significant relationship (Fu et al., 1997; Halldestam, 2009; Tang, 1996; Thijs et 
al., 1990).  
 Cholesterol gallstone formation is a complex process (Belousou, 2006; Temel & Brown, 
2010; Conte, Fraquelli, Giunta, & Conti, 2011). For example, correlations between serum lipids 
levels and gallstone disease may not have a simple answer. Therefore, a multidimensional 
approach may be necessary to investigate how serum lipids levels are associated with other 
environmental factors for developing gallstone formation (Wittenburg & Lammert, 2007).  
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 A study showed that veterans with posttraumatic stress disorder (PTSD) had elevated 
lipids levels (David, Woodward, Esquenazi, & Mellman, 2004) and women in the general 
population were twice as likely as men to develop posttraumatic stress disorder (Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005; Kessler et al., 2005). However, data for the female 
population in relation to lipid levels and risks for cholelithiasis are very limited. 
Comorbidities and Risk Factors  
Metabolic comorbidities and gallstones. Metabolic syndrome is a cluster condition that 
occurs as a combination of high blood pressure, dyslipidemia, abdominal obesity and diabetes. 
Many studies have identified a positive relationship between metabolic syndrome and gallstone 
disease (Ahmed et al., 2014; Tsai et al., 2008; Volzke et al., 2005). Metabolic syndromes rates 
have been observed in societies where “westernized nutrition” prevails. Dietary constituents have 
also been causally linked to metabolic syndromes (Abete, Astrup. Martinez, Thorsdottir, & 
Zulet, 2010). It is believed dietary factors are associated with metabolic syndromes with a higher 
gallstone development rate (Al-Azzawi, Mathur, Swartz-Basile, Nakeeb, & Pitt, 2007; Ruhl & 
Everhart, 2000).  
 Because of the clustered characteristics of the syndrome, metabolic syndrome has not 
been easily diagnosed and it just recently started to be recorded in the Veterans Health 
Administration data, using International Classification of Diseases (ICD)-10 code. Therefore, 
this study was not able to retrieve data on female veterans who were diagnosed with metabolic 
syndrome; however, individual components of the syndromes, such as hypertension, diabetes, 
dyslipidemia, and obesity were all included.   
 Biliary comorbidities and gallstones. Chronic hepatitis C virus may be associated with 
gallstone diseases (Acalovschi, Buzas, & Grigorescu, 2009; Bini & McGready, 2005; Stroffolini, 
21 
Sagnelli, Mele, Cottone & Almasic, 2007). Bini and McGready (2005) found male participants 
who had chronic hepatitis C virus (HCV) infection had higher incidence rate of gallstone 
diseases. Subsequent studies found a positive relationship between HCV virus and symptomatic 
cholelithiasis in both the male and female population (Acalovschi, Buzas, & Grigorescu, 2009; 
Cottone & Almasic, 2007; Stroffolini, Sagnelli, Mele, Cottone & Almasic, 2007). A randomized 
study also described a close relationship between HCV infection, insulin resistance, and 
cholesterol gallstones (Acalovschi, Buzas, & Grigorescu, 2009).  
 Liver cirrhosis and Crohn’s disease are also reported to be risk factors for gallstone 
diseases. Studies have shown these diseases are especially associated with black pigment stones 
(Lammert & Miquel, 2008; Lapidus, Akerlund, & Elnarsson, 2006; Stinton, Myers, & Shaffer, 
2010). It has been found that 25-30% of black-pigmented stones can be attributed to slower 
gallbladder motility, decreased bile salt absorption, and impairment of bile salt synthesis (Buzas, 
Chira, Mocan & Acalovschi, 2011; Vitek & Carey, 2003). Padda et al. (2009) reported there 
were frequent abnormal patterns in liver enzymes, such as aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), and bilirubin among patients with symptomatic cholelithiasis. 
However, the association between those liver enzymes and cholelithiasis development has not 
been fully identified. This study examined the possible risk factors of liver enzymes that include 
aspartate aminotransferase, alanine aminotransferase and total bilirubin and their association 
with cholelithiasis within the study population.  
PTSD and gallstones. Posttraumatic stress disorder (PTSD) has been found to be 
significantly associated with both post deployment physical and chronic mental health disorders 
(Wachen, 2013; Vogt, Proctor, King, & Vasterling, 2008) among the military population. Female 
veterans comprise a growing population with high levels of trauma (Zinzow, Grubaugh, 
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Monnier, Suffoletta-Maierle, & Frueh, 2007), and consequently a high prevalence of PTSD. The 
PTSD rate is higher for women in civilian accidents and for women who witness death or injury 
versus men in identical scenarios (Olff, Langeland, Draijer, & Gersons, 2007). While conditions 
such as PTSD are known to adversely affect quality of life, little is known about the 
consequential effect on disease occurrence.  
 A recent report from the Institute of Medicine noted there was sufficient evidence to 
argue for an association between Gulf War deployment and gastrointestinal disorders, such as 
irritable bowel syndrome and functional dyspepsia in military personnel (National Research 
Council, 2010). Few studies have addressed how military trauma or service-connected 
disabilities are associated with gastrointestinal disorders, although cholelithiasis serves as a 
military disability criterion. A consequence of developing symptomatic cholelithiasis for military 
service members can be military disability status. The relationship between gastrointestinal 
disorders and PTSD in female veterans is notably limited. Thus, this study included the patients’ 
PTSD and disability status in order to determine if occupational risks for cholelithiasis 
occurrences exists among the female military veteran population.  
 Military sexual trauma (MST) has been reported to contributes a wide range of negative 
health outcome that includes anxiety symptoms, increased illicit drug use, and difficulties 
transitioning home after deployment (Decker et al., 2013; Kimerling et al., 2007; Sadler et al., 
2000; Skinner et al., 2000; Stein & Barrett-Connor, 2000). Another study also reported MST 
contributes to the negative effects on mental and cognitive functioning, and eventually impacts 
quality of life (Kimerling et al., 2007). However, no study demonstrates MST is associated with 
an increased risk for gallstone formation. Therefore, this study included the female veterans’ 
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diagnosed MST to determine if MST is an independent risk factor for cholelithiasis occurrence in 
female veterans.   
Causes and Effects of Health with Gallstone Disease 
Studies report symptomatic gallstones not only combine ongoing biliary pain but are also 
attributable to more complicated problems, such as disruption of the gallbladder wall, 
perforation, or even a rupture of the gallbladder (Gupta & Shukla, 2004). Studies have found a 
correlation between cholelithiasis and gastrointestinal and pancreatic cancers (Anderson, Potter, 
& Mack, 1996; Sanders & Kingsnorth, 2007; Schernhammer et al., 2003; Siddiqui et al., 2009). 
Studies have also found that the overall mortality rates are increased with cholecystectomy 
surgeries. Although a cholecystectomy is considered one of the most common surgeries in the 
United States, it is not a benign procedure. Scientific studies have indicated gallbladder surgeries 
have a high association with gastrointestinal cancers. The studies found significant numbers of 
patients developed esophageal and colon tumors following cholecystectomy surgeries 
(Freedman, Ye, Naslund & Lagergren, 2001; Goldacre, Abisgold, Seagroatt & Yeates, 2005; 
Lagergren, Ye, & Ekbom, 2001; Nogueira et al., 2014; Schernhammer et al., 2003; Shao & 
Yang, 2005; Siddiqui et al., 2009). Yet other studies have not found a significant relationship 
between the incidences of tumors resulting from cholecystectomy surgeries (Mercer, Reid, 
Harrison & Bates, 1995; Reid, Mercer, Harrison & Blates, 1996). In addition, some studies were 
concerned with the complications of laparoscopic cholecystectomies that were often associated 
with infection, bleeding, biliary leakage, postoperative complication, anesthesia related 
complication and possible repeat surgery (Pérez et al., 2006; Pottakkat et al., 2010; Waage & 
Nilsson, 2006).  
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Theoretical Framework 
 With the rising prevalence of cholelithiasis, attention is being increasingly focused on 
identifying the risk factors associated with cholelithiasis occurrence. An emphasis on 
identification of principle risk factors facilitates a greater understanding of the pathophysiology 
of gallstone formation. Wittenburg and Lammert’s (2007) Factors Contributing to Cholesterol 
Gallstone Susceptibility were the primary concepts used herein. The theory’s major concepts are 
defined and the major linkages are identified in the following section.  
General Description 
 The fundamental belief of Wittenburg and Lammert’s physiological model is that 
gallstone formation is due to multifactorial influences. The Wittenburg and Lammert’s model 
indicated, there is a rare chance to develop gallstones based only a single gene. In most cases, 
gallstones develop as a result of interaction among genetic factors, geographical and ethnic 
differences, and environmental factors. This indicates that gallstone formation occurs by the 
interaction among complex genetic predispositions and multiple environmental factors 
(Wittenburg & Lammert, 2007).  
 For example, Mexican and American Indian ethnic groups were detected as having 
human leukocyte antigen allele characteristics that were closely related to gallstone prevalence. 
Although this was a predisposing factor of a gene, the disease became endemic only with severe 
environmental changes that occurred after abandoning their traditional lifestyle and adapting a 
western-type diet. It showed that the genetic variation of the American Indian that increased the 
ability to store fat was beneficial in times of poverty, but it became detrimental following 
environmental changes that increased susceptibilities to weight gain, diabetes, and gallstone 
formation (Wittenburg & Lammert, 2007).  
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 In addition to geographical variation and ethnic differences in gallstone prevalence rates, 
genetic predisposition was highly associated with gallstone occurrences (Covarrubias, Valdivieso 
& Nervi, 1984; Hanis et al., 1993; Maurer et al., 1989). Studies reported individuals with family 
history of gallstones had a two to five-fold increased risk for cholelithiasis among first-degree 
relatives of a gallstone carrier (Attili et al., 1997; Barbara et al., 1987). These rates were even 
higher in monozygotic twins at 12% and dizygotic twins at 6%
 
(Gilat, Feldman, Halpern, Dan, & 
Bar-Meir, 1983; Sarin, Negi, Dewan, Sasan, & Saraya, 1995).  
 The inflammatory response in chronic liver diseases reduced the capacity of the liver to 
produce glucuronidate bilirubin. This is the process in which the liver makes bilirubin water-
soluble so it can be excreted into the small intestine and be eliminated in stools. Biliary secretion 
of bile salts is impaired and results in the increased formation of bilirubin gallstones in liver 
cirrhosis (Conte et al., 1999). In this case, the additional influence of environmental factors to the 
gallstone risk appears to be somewhat small (Conte et al., 1993). Cholelithiasis is positively 
associated with the severity of liver disease but not contributed by the cause of cirrhosis (Conte 
et al., 1999; Conte et al., 1993).  
 The factors contributing to cholesterol gallstone susceptibility are presented in a diagram 
(Figure 1). The individual contributing factors do not increase gallstone susceptibility but lead to 
gallstone development by interacting with each other, as indicated by the arrowheads pointing in 
both directions.  
 The above illustrated physiological model, entitled Factors Contributing to Cholesterol 
Gallstone Susceptibility, guided this study examining gallstone formation as a multifactorial 
phenomenon. Multiple environmental risk factors that surround patients should be examined in  
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Factors Contributing to Cholesterol 
Gallstone Susceptibility 
 
Figure 1. Factors contributing to cholesterol gallstone susceptibility. (Wittenburg & Lammert, 
2007) 
order to identify the associational factors of cholelithiasis occurrence. Also, geographical 
variation and ethnic differences should be included in the consideration of identifying 
predisposing factors associated with gallstone diseases. The application of the physiological 
model to the current study is explained in Figure 2. This current study consisted of independent 
variables that are presented in Figure 2, which identifies the relationship between the 
independent variables and cholelithiasis occurrence among female veterans.  
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Factors Applied to Cholelithiasis Occurrence 
 
Figure 2. Wittenburg & Lammert’s (2007) Factors contributing to cholesterol gallstone 
susceptibility adapted by Pak (2015). Acronym for diabetes (DM), hypertension (HTN), hepatitis 
B (Hep B), hepatitis C (Hep C).  
 
Summary 
 Cholelithiasis is one of the costliest digestive disorders to treat in the United States 
(American Gastroenterological Association, 2001). Preventive control is a crucial key for 
reducing chronic cholelithiasis complications. Studies have shown advanced age, female gender, 
and certain ethnicities are considered to be non-modifiable factors, while serum cholesterols, 
body weights, and co-existing diseases appears to be modifiable factors for preventing gallstone 
risks.  
 Although extensive research literature has tried to identify the risk factors for 
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cholelithiasis, answers still remain unclear. Studies with a multidimensional approach should be 
employed to examine populations with cholelithiasis. Further, limited data demands the 
identification of multifactorial association of gallstone formation in the fast growing population 
of military female veterans.     
 The physiological framework of the contributing factors for cholesterol gallstones 
proposed a significant relationship between multifactorial risk factors and cholelithiasis 
occurrence. Therefore, cholelithiasis should be understood as a result of combining factors with 
the geographical and ethnic differences, the associations among multiple environmental factors 
and the risk for developing gallstones in female veterans were evaluated in this study.   
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CHAPTER III 
METHODOLOGY 
This chapter describes the design and research methodology that was used to examine 
possible relationships between risk factors and the occurrence of cholelithiasis among female 
veterans. This chapter includes research design, sample and settings, data collection, plan for 
analysis, data analysis and management, and summary of the study.  Data analyses are discussed 
separately for each of the specific aims. 
The overall aims examined in this study are as follows: 
1)  Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis.  
2)  Examine differences among metabolic, liver enzyme and serum lipid laboratory data 
in female military veterans with and without cholelithiasis.  
3)  Explore differences between diagnosed metabolic and biliary comorbidities 
experienced by female military veterans with and without cholelithiasis.  
4)  Explore associations among demographic, environmental, laboratory data and 
diagnosis of comorbid conditions among female military veterans with and without 
cholelithiasis.  
Study Design 
 The study design is a retrospective case control study in which the characteristics of 
female veterans with and without cholelithiasis were compared and analyzed. A case-control 
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study design allows for relative ease of large sample recruitment (Pedhazur & Schmelkin, 1991; 
Stevens, 2002). A retrospective approach contains several benefits including: a) a relatively 
inexpensive ability to research the readily accessible existing data; b) easier access to conditions 
where there is a long latency between exposure and disease allowing for the study of rare 
occurrences; and c) the generation of hypotheses that then could be tested prospectively (Hess, 
2004).
 
The retrospective case control study also allows for examination of multiple risk factors 
associated with the development of cholelithiasis among geographically diverse female veterans 
with a nationwide random collection of data. 
 According to the literature, multidimensional risk factors may contribute to cholelithiasis 
occurrence (Heaton, Braddon, Mountford, Hughes & Emmett, 1991; Wittenburg & Lammert, 
2007). Research that aims to identify risk factors for the outcome of the disease should also 
consider multiple covariates as potential contributors associated with the outcome. For this study, 
Wittenburg and Lammert’s (2007) Factors Contributing to Cholesterol Gallstone Susceptibility 
was used as the theoretical framework. Wittenburg and Lammert conceptualized cholelithiasis as 
a multifactorial phenomenon resulting from an interaction with multiple predisposing factors. 
Multiple regressions were planned to explore multiple predisposing risk factors that lead to 
cholelithiasis development.  
Sample and Setting 
Eligible female veterans who were over 40 years of age and enrolled in the Veterans 
Healthcare Administration (VHA) system from January 1, 2008 to December 31, 2013 were 
considered for inclusion in this study. Only those who had all required information, including 
demographics, laboratory, medication records, problem lists, and administrative records were 
included for either the case or control groups. The sample size was determined using calculations 
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by the G* power 3 software program (Faul, Erdfelder, Lang, & Buchner, 2007). Data 
constituting a subset of 242 female veterans who were diagnosed with cholelithiasis during the 
study period were randomly selected to be compared to an equivalent number of controls 
selected from the pool of patient who had no diagnosis or history of cholecystectomy. The 
sample size of 484 for two groups was sufficient to meet a statistical power of 80%, and an alpha 
of 0.05. Therefore, a sample size of 242 subjects in each of the case and control groups was 
determined to be sufficient to obtain statistical significance.  
Inclusion/Exclusion criteria for selection of sample data included: 
1) Female veterans who were enrolled in the Veterans Health Administration (VHA) from 
January 1, 2008 to December 31, 2013 and were over 40 years of age.  
2) Female veterans who were seen and had at least one or more of serum laboratory test 
results during the study period were included. 
3) Only female veterans who were diagnosed with cholelithiasis (using ICD-9 Electronic 
diagnosis designation and recorded as such by the VHA system) during the study period 
were selected for the case group.  
4) Samples were assigned to the control group if they met criteria 1) and 2) they did not 
have medical or surgical documentation of cholelithiasis or a cholecystectomy during the 
study period.  
Exclusion Criteria  
1) Female veterans who had not had medical care by the VHA system between the dates of 
January 1, 2008 to December 31, 2013 were excluded.  
2) Female veterans who were 40 years of age or younger at the time of diagnosis of 
cholelithiasis or other diagnosis (control) were excluded. 
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3) Female veterans with no laboratory results during the study time were excluded.  
This retrospective case control study examined the relationship among multiple risk 
factors and cholelithiasis occurrence. The multiple risk factors were considered as independent 
variables while the occurrence of cholelithiasis was considered as a dependent variable. The 
independent variables were selected to be studied based upon evidence in the literature of factors 
associated with cholelithiasis occurrence. The independent study variables included demographic 
data (age, race, Body Mass Index (BMI), marital status) and environmental factors (length of 
military service, percentage of military disability, exposure to combat zones, use of alcohol and 
tobacco, and use of female hormones), metabolic laboratory tests (fasting glucose, hemoglobin 
A1C), liver enzymes (bilirubin, alanine transaminase (ALT), aspartate aminotransferase (AST)), 
serum lipid profile (total cholesterol, High Density Lipoprotein (HDL), Low Density Lipoprotein 
(LDL), triglycerides), and the diagnosed of comorbidities (diabetes, hypertension, dyslipidemia, 
hepatitis B, hepatitis C, liver cirrhosis, Crohn’s disease, posttraumatic stress disorder (PTSD) and 
military sexual trauma (MST)). The dependent variable was determined by two groups, female 
veterans with (case) and without cholelithiasis (control). 
Data Collection 
 
 This retrospective study was conducted, using a proprietary research database system 
called the Veteran Affairs Informatics and Computing Infrastructure (VINCI). The VINCI is a 
nationalized Veterans Health Administration infrastructure system that was developed to 
improve researchers’ access to the VHA data while securing the privacy and data security of the 
military veteran. Each individualized VINCI virtual setting was named by the principal 
investigator’s last name combined with the study request number. Only the principal investigator 
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and the principal investigator’s appointed personnel, a computer engineer, a data manager, and a 
data counselor for this study, were allowed to access the data through the VINCI system.   
The Veterans Health Administration (VHA) is known to have one of the largest 
repositories of electronically collected administrative and national healthcare data (Fihn et al., 
2013). The VHA’s database allows a unique opportunity to study a large segment of the 
population (military women who have previously served their country) with various age ranges, 
comorbidities, and clinical epidemiology.  
After obtaining the approval from the Institutional Review Boards (IRB) of both at the 
Veteran Health Administration in Orlando, Florida and the University of North Dakota, the 
protocol for this study was reviewed by the VHA’s National Security Data Service, privacy 
protection service, and the Veterans Affairs Informatics and Computing Infrastructure (VINCI). 
Once IRB approvals were obtained from the university and the four VHA agencies, a designated 
VINCI data manger retrieved a dataset per the principal investigator’s inclusion/exclusion 
criteria, and stored the study cohort in a virtual setting in the VINCI by Structured Query 
Language (SQL) Server Management System. The International Classification of Diseases 9th 
Revision (ICD-9) diagnosis codes were used when accessing the VHA data to identify 
populations of female veterans with cholelithiasis (ICD-9: 574) and with ones who had a history 
of cholecystectomy (ICD-9: 51.2).  
Data samples from 242 military veteran women with and without cholelithiasis were 
randomly pulled through the VINCI system. The samples were retrieved for these patients who 
received health care between the dates of January 1, 2008 to December 31, 2013 using a 
systematic random sampling (LaerdDisseration, 2012). In accessing the VHA data, tables were 
linked together using a unique numeric identifier in columns. No actual patient identification was 
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used but national integration control numbers and scrambled social security numbers made it 
possible to identify the patients. 
The samples representing both groups met inclusion criteria (See Figure 3). Data was 
entered into a Microsoft Excel spreadsheet and numerically coded. The same data was entered 
twice and compared as a means of minimizing any possible data entry errors. The information 
was stored in a secure and password-protected server. The detailed process of the sample 
collection is displayed in Table 1.  
 
Figure 3.  Selection criteria. 
Note. *Sufficient data was considered to have at least one or more updated laboratory test results 
during the study period. Patients’ health conditions are updated when test results are reported in 
the VHA system. * * Insufficient data was considered if no updated laboratory test result were 
found during the study period.  
Female veterans over 40 
years age enrolled in the 
VHA system for health 
care at any time from 
Jan 1, 2008- Dec 31, 
2013 
With Cholelithiasis  
Diagnoses with 
cholelithiasis according 
to ICD-9 coding 
Include: 
*One or mote 
laboratory tests during 
the study period.  
With cholelithiasis  
N= 242 
Exclude: 
** Women with no 
laboratory testing during 
the study time period. 
Without Cholelithiasis  
Include: 
 * One or more 
laboratory test during 
the study period. 
Without Cholelithiasis 
N= 242 
Exclude:  
** Women with no 
laboratory testing during 
the study time) 
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Table 2.  The Process of Scripts for the Sample (Cholelithiasis Group) Data Collection. 
 
 
Step 
    
Comments 
 
 
1 
 
Establish base set 
  
Merged the cohort tables, which contain all patients who 
were seen from January 1, 2008 to December 31, 2013. 
 
2 Identify and remove 
duplicates from base set 
 Duplicate data was filtered out using female veterans’ 
unique VHA number associated with scrambled social 
security number.  
 
3 Add age and exclude those 
were younger and aged 40 
years old when diagnosed 
of cholelithiasis and ex-
cluded without date of birth 
 
 Joined the base set to S patient data. S patient data is where 
the date of birth stored. 
 
 
 
 
4 Add race into base set  Joined the base set to Patient race table where race is stored. 
 
5 Finalize and save out dataset 
as table “cholelithiasis 
group” 
 Ensure this data set included information, such as date of 
birth, cholelithiasis diagnosis data, age at diagnosis, race.  
 
6 Gather military service 
information 
 The table supplied had sparse military service information, 
and the information was also obtained external data from 
VetNet. The two datasets were merged, duplicates were 
excluded, and the results saved after merging into the base 
set. 
 
7 Add Disability into base set  Joined the base set to the disability table for the test group 
and excluded duplicates.  
 
8 Add laboratory results into 
base set 
 Filtered the results of laboratory tests with keywords of 
tests’ name and excluded the results if they were not within 
the study period. Then, the laboratory results were merged 
into the base set. 
 
9 Add disease information 
(with ICD-9 code) to base 
set 
 Detected comorbid diseases using the identified ICD-9 
codes for each sample in the base set. Then, the obtained 
each individual’s comorbid diseases were merged into the 
base set  
 
10 Merge all into one table   Merged all data into one data sheet in Excel.  
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The process of sample collection for the control group followed the same steps as the 
cholelithiasis group as shown in Table 1, except step 5. Instead of using cholelithiasis diagnosis 
data for case group, the control group used a diagnosis date for any other diseases during the 
study period and the first diagnosis date was included to measure the participant’s age.  
Throughout this study, the principle investigator’s virtual setting in the VINCI was 
monitored by the designated data manager, the VINCI data security, and the national data 
security. In addition, the principle investigator’s appointed computer for the study was monitored 
by the VINCI data security, the national data security and the VHA information resources 
manager in the VHA Orlando, Florida.  
Plan for Analysis 
Dependent Variables 
 The two study groups (dependent variables) were: 1) Women diagnosed with 
cholelithiasis (case group) and coded as Group“1”; and 2) Women not diagnosed with 
cholelithiasis or did not have cholecystectomy during the study period (control group) and coded 
as Group ‘0’. To identify the potential effect of risk factors on the occurrence of cholelithiasis, 
the female veterans with and without cholelithiasis groups were compared.  
Independent Variables 
Independent variables were identified and compared against the questionnaire used in Dr. Walter 
Willett’s Health Professionals’ Follow-up Study (HPFS) for gallstone disease with Dr. Willett’s 
permission. The HPFS began in 1986 as a prospective study, follow up questionnaires were sent 
biannually to update participants’ health information, such as demographics, medical history, 
anthropometrics (height, weight and body mass index), life style factors (diet, physical activity, 
cigarette smoking, and alcohol use), and comorbidities, including gallstone disease (Willett, 
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2006). The responsiveness to this questionnaire was reported over 90% (Willett, 2006) and the 
individual variables in the questionnaire were tested in other studies (Martinez-Gonzalez et al., 
2004; Leitzmann et al., 1999). Tsai et al.’s prospective study (2004a), abdominal adiposity and 
gallstone, validated of the body mass index (BMI) and waist circumstances used in the HPFS by 
comparing 125 participants’ self-assessed information to those measured by a technician that 
demonstrated the validity of BMI in relation to a symptomatic cholelithiasis. The questionnaire 
has been used extensively in many other gallstone studies (Leitzmann et al., 2003; Tsai, 
Leitzmann, Willett, & Giovannucci, 2005a; Tsai, Leitzmann, Willett, & Glovannucci, 2005b). 
The variables for this study were compared and then modified from the questionnaire in the 
HPFS because it is a retrospective study using electronic medical records.  
Demographics. Age, race/ethnicity, Body Mass Index, and marital status were compared 
to the dependent variable. Age at the time of the disease diagnosis was used as the case sample’s 
age by deducting the time from their birth date. The age of participants in the control sample was 
measured using the diagnosis of their first disease to be treated during the study time by 
deducting their birth date. Analyses of frequency rates for cholelithiasis according to intervals of 
age were arranged in five years increments: the first interval was 41-45 years of age and so on  
(e.g., 41-45 years, 46-50 years, 51-55 years…76-80 years, >81 years). The control group was 
matched with the case group based on the age to have similar distribution across confounding 
variables. A bigger age variation can impact the study outcome since age is one of the strongest 
risk factor that affects cholelithiasis occurrence. The height and weight when the patients were 
diagnosed of the disease were selected for case and control group to measure their body mass 
index (BMI). Body Mass Index (BMI) was calculated using the formula, weight (lb) / height
 
(in
2
).  
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Ethnicity was divided into six groups as listed in the VHA data to include: 1) 
Caucasian (white), 2) African American (black), 3) Asian, 4) American Indian or Alaska 
Native, 5) Native Hawaiian or other Pacific Islander, and 6) Unknown. Samples that were 
recorded in the VHA data as unknown, refused to answer, or unable to identify ethnicities 
were all labeled as unknown in the ethnicity data. Marital status was identified only with or 
without spouse since it was listed as such in the VHA data.  
Environmental characteristics. Length of military service was measured by deducting 
the military service end date from the start time and recorded as months. Military disability status 
was presented as a percentage of the disability in the VHA data, and the total disability 
percentage was measured by adding all disability rates. Other information, such as use of alcohol 
and tobacco, use of female hormones, exposure to military combat zones were included to 
expand the understanding of the women’s occupational factors that might have contributed to the 
development of cholelithiasis. The information about consumption of alcohol or tobacco, use of 
hormone therapy (contraceptive or postmenopausal female hormone), and exposure to combat 
zones were listed as binary data because the information were retrieved using ICD-9 code. 
Therefore, it was only possible to identify whether the female veterans had the exposure “1” or 
no exposure “0” in the VHA system.  
Serum laboratory tests. Serum laboratory tests were retrieved from supplied laboratory 
data set by putting identified names of tests. Although it was not possible to identify how the 
samples were obtained and stored in the VHA system, all laboratory tests and result reports at the 
VHA were followed the federal regulation of the Clinical Laboratory Improvement Amendments 
(CLIA) (VHA Handbook 1106.01, 2008). CLIA has established quality standards for all 
laboratory tastings to ensure the accuracy, reliability and timeliness of patient test results 
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regardless of where the test was performed (VHA Handbook 1106.01, 2008). The value of 
laboratory tests was collected from the laboratory data using keywords, as displayed in Table 3.  
Table 3.  Keywords Used to Retrieve the Serum Laboratory Results. 
  
 
Category  
 
Test 
 
Keywords  
 
 
Metabolic  
 
Fasting glucose 
 
 
Hemoglobin A1C (HbA1C) 
 
Fasting glucose, glucose fasting, and 
serum fasting glucose 
 
Fasting hemoglobin A1C, fasting 
serum hemoglobin A1C, and fasting 
A1C, fasting HbA1C for hemoglobin 
A1C 
 
Liver 
Enzymes 
Alanine transaminase (ALT) 
 
 
 
 
 
 
 
Aspartate aminotransferase 
(AST) 
 
 
 
 
 
 
Bilirubin 
 
Alanine transaminase, serum alanine 
transaminase, fasting alanine 
transaminase, ALT, serum ALT, 
Serum glutamic Pyruvate 
Transaminase, glutamic Pyruvate 
Transaminase, SGPT, and serum 
SGPT. 
 
Aspartate aminotransferase, serum 
aspartate aminotransferase, fasting 
aspartate amionotransferase, AST, 
serum AST, serum glutamic 
oxaloacetic transaminase, glutamic 
oxaloacetic transaminase, SGOT, and 
serum SGOT 
 
Total bilirubin, serum total bilirubin, 
fasting total bilirubin, and bilirubin 
total.  
 
Lipid 
Profile  
Total cholesterol, High-density 
lipoprotein (HDL) cholesterol, 
Low-density lipoprotein 
(LDL), triglycerides  
 
Lipid profile, fasting lipid profile, 
serum lipid profile, total lipid profile, 
and complete lipid profile 
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The serum laboratory tests were selected at a time cholelithiasis was diagnosed during the 
study period for the cholelithiasis group. The laboratory tests at any time during the study period 
were used for the control group. Mean laboratory values were compared between female 
veterans with and without cholelithiasis.  
Comorbidities. The International Classification of Disease (ICD)-9 codes were used to 
verify the samples’ comorbidities. The selected study samples were verified to contain certain 
diagnosed comorbidities of diabetics, hypertension, dyslipidemia, hepatitis B, hepatitis C, liver 
cirrhosis, Crohn’s disease, posttraumatic stress disorder, and military sexual trauma. To verify 
the updated diagnosed of comorbidities, only female veterans who had at least one or more 
laboratory test results during the study period were included. Patients’ health conditions are 
updated by their physicians when tests are ordered, and results are reported in the VHA system. 
Data Analysis and Management 
Descriptive statistics were used to compute frequencies, percentages, means and standard 
deviations of the independent variables. Histogram and bar plots were presented to visualize 
distributions of the frequency of occurrence for the values. The cholelithiasis group was matched 
to non-cholelithiasis group based only on age (+ 5 years) to avoid the findings of the study being 
confounded by the effects of age. Matching with age is particularly important in order to avoid 
the latency period for developing cholelithiasis. Each factor of the independent variable was 
compared and analyzed for the groups of female veterans with and without cholelithiasis, using 
independent sample t-tests for continuous variables and chi-square (2) tests for categorical 
variables. Person’s product moment correlations were used to investigate the individual 
relationships between each continuous variable and dependent variable.  
 As a final step, multiple regression analysis was used to determine risk factors for 
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cholelithiasis in female veterans while accounting for potential confounding effects (Kleinbaum, 
Kupper, Muller, & Nizam, 1997; Kutner, Nachtsheim, Neter, & Li, 2004). If there was a 
significant relationship from the multiple regression, the independent variable could improve the 
accuracy in predicting values for the dependent variable.  
 Forward stepwise regressions (Grechanovsky, 1987) were performed to reduce the number 
of potential effects of confounding variables, with only those variables remaining in the equation 
that had a significant p value of ≤ .05. Goodness of fit was performed to verify an overall fit test 
of the model using chi-square (X
2a
). Also Odds Ratio (OR) with its 95% confidence interval 
(95% CI) and R
2
 were measured to analyze the strength of the relationship between the set of 
independent variables and the dependent variable. A statistical significance level was calculated 
at p ≤ .05. All statistical data analysis was performed by using the Statistical Package for the 
Social Science (SPSS version 22, Armonk, NY). The following section describes how this study 
reduced discrepancies from missing data.  
Missing Data 
 Large data sets, such as the VHA data may contain legitimately missing data (Milbank, 
2002). Missing data can potentially skew the results (Cole, 2008), and it is necessary to deal with 
the missing data. A benefit of a retrospective big data study is that it can include a large number 
of patients’ representative actual patient medical records. Although the missing data in this study 
was distributed randomly, it had the potential effect of reducing the sample size and power of the 
study.  
 For an effective statistical analysis with SPSS, pairwise deletion was used to include all 
available data in analysis. In order to maintain power, pairwise deletion was useful for this study 
because of missing values at random distribution. Additionally, comparisons among independent 
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variables given dependent variables were computed based on mean values of all available data.  
Management of Outliers 
 In order to successfully identify outliers, statistical and graphical methods were used. 
Independent variables were examined the distribution of observations, and selected as outliers 
that the values falling at the outer ranges of the distribution. Boxplots and scatterplots were used 
to detect values outside two of standard deviations of the mean value.  Further, the outliers were 
examined manually to identify the causes of outliers, whether they were from error or uniqueness 
for accuracy of the data. Finally, the goodness of the fit by SPSS was performed to measure of a 
better fitting by comparing the baseline including outliers and the model without the outliers. 
The model, which proved to be a better fit, was chosen for the regressions. 
Data Analysis 
The Data Analysis plans for each Specific Aim are explained as follows: 
 
Specific aim 1. Determine the demographic and environmental characteristics of female 
military veterans with and without cholelithiasis.  
Descriptive statistics measured risk factors of female veterans with and without 
cholelithiasis were stratified to visualize what the data was showing. The frequencies and 
distributions of independent variables were expressed in mean and standard distribution for 
continuous variables and counts and percentage for categorical variables. Continuous variables 
included years of age, BMI ratios, months of military service and percentages of military 
disability. Categorical variables included race, branches of military service, and yes/ no 
responses to marital status, use of alcohol, tobacco, and female hormones.  
 Independent sample t-tests were performed to examine the difference between females 
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with and without cholelithiasis on the given continuous variables. The Chi- Square tests of 
independence were used to determine the association between two categorical variables. A p-
value ≤ .05 indicated the variable of interest was significantly different between the case and 
control groups. A p-value ≤ .05 was used to reject the null hypothesis that none of the 
independent variables were significant. In other words, if at least one of the independent 
variables is significant, the null hypothesis is rejected. All the statistical analysis was performed 
in SPSS. 
 Specific aim 2. Examine differences among metabolic, liver enzyme and serum lipid 
laboratory data in female military veterans with and without cholelithiasis  
 The laboratory data were summarized using independent sample t-tests. Mean values of 
metabolic tests included to fasting glucose, hemoglobin A1C, liver enzymes (alanine 
transaminase (ALT), aspartate aminotransferase (AST), bilirubin) and lipid profile were 
presented with standard deviations (SD). The mean differences of the laboratory data were 
compared between female veterans with and without cholelithiasis and the p-value associated 
with each test was reported. Bar plots were reported to show mean comparisons of significant 
laboratory tests in female veterans with and without cholelithiasis.  
 A p-value ≤ .05 was used to reject the null hypothesis that none of the laboratory tests 
were significantly associated with cholelithiasis occurrence in female veterans. 
 Specific aim 3. Explore differences between diagnosed metabolic and biliary 
comorbidities experienced by female military veterans with and without cholelithiasis  
Frequencies of metabolic (diabetes, dyslipidemia, hypertension), biliary (hepatitis B, 
hepatitis C, liver cirrhosis) and other (Crohn’s disease, posttraumatic stress disorder (PTSD), 
military sexual trauma (MST)) were summarized using descriptive analysis.  
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Comorbid conditions were referred to as binary variables (either the disease was present 
or not). These variables were coded for either “0” no disease or “1” had disease. The association 
between binary variables in female veterans with and without cholelithiasis was measured using 
the Chi-Square independent test. The p-value associated with each test was reported. 
A p-value ≤ .05 indicated a diagnosed comorbidity was significantly different between 
females with and without cholelithiasis. A p-value ≤ .05 was used to reject the null hypothesis 
that none of the comorbid conditions were significantly associated with cholelithiasis occurrence 
in female veterans. 
Specific aim 4. Explore associations among demographic, environmental, laboratory data 
and diagnosis of comorbid conditions among female military veterans with and without 
cholelithiasis.  
The associations among independent (continuous) variables in female veterans and risk 
for cholelithiasis occurrence were examined using Pearson product moment correlations. The 
purpose of using statistical correlation was to identify whether there was a significant 
relationship among independent variables and cholelithiasis occurrence in female veterans. A 
two-tailed test with a significance level of .05 was used to include the possibility of the 
relationship in both direction associated with cholelithiasis occurrence. An r-value was measured 
to demonstrate the strength and direction of liner relationships between the continuous variables 
and cholelithiasis occurrence and p-value was also reported. A p-value ≤ .05 indicated an 
independent variable was significantly associated with cholelithiasis occurrence.  
Multiple logistic regressions were used to explore associations among the independent 
variables (use of alcohol, use of tobacco, use of female hormones, and all comorbid diseases) and 
binary dependent variables (cholelithiasis or no-cholelithiasis). Also multiple linear regressions 
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were used to evaluate associations among the independent variables, such as laboratory data and 
the risk of cholelithiasis occurrence. The independent variables were considered for logistic 
regression analysis based on a liberal alpha of 0.05 from the bivariate comparisons to avoid 
omission of potentially important variables.  
Using stepwise regressions, the individual values of significant variables were identified 
for the productiveness of the dependent variables. Each associated variable was either entered or 
removed based on a statistically significant value until they were no longer significantly 
contribute to the model. Adjusted odds ratio (OR) was obtained through stepwise regression 
while other risk factors were controlled. The 95% confidence interval (CI) was used to estimate 
the precision of the adjusted odds ratio. 
Summary 
 In summary, the purpose of this retrospective study was to identify relationships among 
predisposing risk factors and gallstone occurrence in female veterans. Descriptive analysis was 
expressed in frequencies and distributions of the data. The differences in female veteran with and 
without cholelithiasis on given independent variables were calculated using independent t-tests 
and chi-square tests. Pearson product moment correlations were used to demonstrate the strength 
and direction of relationships among independent variables and cholelithiasis occurrence in 
female veterans. Finally, multiple regressions were used to identify risk factors associated with 
cholelithiasis occurrence while accounting for potential confounding effects.  
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CHAPTER IV 
 
RESULTS 
 
The purpose of this study was to identify the relationship between predisposing risk 
factors and cholelithiasis occurrence in military female veterans. The specific aims of the study 
were to: 
1)  Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis.  
2)  Examine differences among metabolic, liver enzyme and serum lipid laboratory data 
in female military veterans with and without cholelithiasis.  
3)  Explore differences between diagnosed metabolic and biliary comorbidities 
experienced by female military veterans with and without cholelithiasis.  
4)  Explore associations among demographic, environmental and laboratory data and 
diagnosis of comorbid conditions among female military veterans with and without 
cholelithiasis 
This chapter presents the findings of this study including: a description of the sample 
from which the data were derived, results of the descriptive and inferential statistical analysis, 
along with significant findings for each aim. Statistical analysis was conducted using Statistical 
Package for the Social Science (SPSS Versions 22, Armonk, NY).  
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Specific Aims 
Specific Aim 1 
Aim 1. Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis.  
Demographic characteristics. The medical data for 484 military female veterans aged 
41 years and older were examined for this study. Two hundred forty two data of female veterans 
diagnosed with cholelithiasis from January 1, 2008 to December 31, 2013 were randomly 
collected for the cholelithiasis group. The same numbers of female veterans without a diagnosis 
of cholelithiasis or a history of cholecystectomy during the same period were randomly selected 
for a group without cholelithiasis. The study data were retrieved from the Veterans Health 
Administration (VHA) database according to the inclusion criteria. Detailed information about 
the criteria and steps for the data collection were explained in Methods, Chapter III. 
Demographic data for the sample is reported as follows (Table 4). 
 
Table 4.  Demographic Characteristics of Female Veterans With and Without Cholelithiasis. 
 
  
 
 
 With Cholelithiasis             
(n= 242) 
  
 
 Without Cholelithiasis                  
(n= 242) 
Characteristics 
 
           n 
 
% 
 
  
           n 
 
           % 
 
      
Age      
41- 45 yrs 14 5.8 
 
14 5.8 
46- 50 38 15.7 
 
38 15.7 
51-55 59 24.5 
 
59 24.5 
56-60 56 23.1 
 
56 23.1 
61-65 33 13.7 
 
33 13.7 
66-70 20 8.3 
 
20 8.3 
71-75 6 2.4 
 
6 2.4 
76-80 5 2 
 
5 2 
>81 11 4.5  11 4.5 
Total 242 100 
 
242 100 
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Table 3 cont.      
      
  
 
 
With Cholelithiasis 
(n= 242) 
 
 
With Cholelithiasis 
(n= 242) 
Characteristics 
 
               n 
 
% 
 
  
           n 
 
% 
 
      
Race/ethnicity 
     
White 167 69 
 
188 77.7 
Black or 
African 
American 
66 27.3 
 
48 19.8 
merican 
Indian 
0 0 
 
1 0.4 
Asian 1 0.4 
 
1 0.4 
Native 
Hawaiian or 
Pacific 
4 1.7 
 
4 1.7 
Islander 
     
Unknown 4 1.7  0 0 
Total 242 100 
 
242 100 
      
Marital status 
(spouse) 
     
Yes 8 3.3 
 
19 7.9 
No 97 40.5 
 
44 18.2 
Unknown 
Total 
 
137 
242 
 
56.2 
100 
 
 
179 
242 
 
74 
100 
 
 
 
The intervals of age were set as follows: 41- 50 years, 51-55 years, 56-60 years, 61-65 
years, 66-70 years, 71-75 years, 76-80, >81 years. The most prevalent age group at diagnosis was 
51 to 60 years of age as shown in Figure 4. The age distribution between the two groups was 
identical due to the purposive matching based on age.  
The mean age of the female veterans with cholelithiasis was 58.41 and the mean age of 
female veterans without cholelithiasis was 57.41 with a range of ages from 41 to over 81 years. 
The mean Body Mass Index (BMI) was slightly higher in females with cholelithiasis (M= 31.64, 
SD= 7.30) than those without cholelithiasis (M=30.56, SD=7.87). However the difference was 
not statistically significant (t = 1.09, p= .14), as shown in Table 5.  
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Figure 4. Female veterans’ age at diagnosis with cholelithiasis. 
Table 5.  Age and Weight Comparisons Between Female Veterans With and Without 
Cholelithiasis. 
 
 
       n M   SD  t    p 
 
Age at Diagnosis (years) 
     
 Cholelithiasis 242 58.41 9.97 >1.09 0.28 
 No-cholelithiasis 242 57. 41 10.05   
 
Body Mass Indexes      
 Cholelithiasis 242 31.64 7.3 >1.49 0.14 
 No-cholelithiasis 194 30.56 7.87   
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The most common ethnic group studied were Caucasian females with and without 
cholelithiasis. The percentage of Caucasian female veterans with cholelithiasis was 69.0% and 
those without cholelithiasis was 77.7%. African Americans were the second most common 
ethnic group studied. Of African American females, 27.3% had cholelithiasis while 19.8% did 
not. There were not significant differences in ethnicity between two groups. The comparison in 
ethnicity distribution in females with and without cholelithiasis is presented in Table 6. 
Table 6. Frequency of Female Veterans With and Without Cholelithiasis by Ethnic Categories. 
 
  
 
 
 With Cholelithiasis              
  
 
 Without Cholelithiasis                   
Ethnicity 
 
           n 
 
          % 
 
  
           n 
 
           % 
 
Caucasian  167 69.0  188 77.7 
African American  66 27.3  48 19.8 
American Indian  0 0  1 0.4 
Native Hawaiian  4 17  4 1.7 
Asian  1 .4  1 .4 
Unknown 4 1.7  0 0 
Total  242 100   242 100 
       
The number of female veterans who were identified as neither Caucasian nor African 
American was too small to compare the differences between groups. The ethnic distribution of 
female veterans with and without cholelithiasis is described in Figure 5. 
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Figure 5. Bar graph representing ethnic groups of female veterans with and without 
cholelithiasis.  
 
 
Environmental characteristics. Military female veterans are women who served for 
any length of time in any military branch. Due to their unique occupational experience, 
occupational factors may be directly related to women’s health. Environmental 
information, such as the branch of military service for each woman is displayed in Table 7. 
There was only one female veteran in the cholelithiasis group deployed to warzones; 
therefore it was not possible to identify whether a warzone exposure contributed to 
increased risk for cholelithiasis among female veterans. 
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Table 7.  Environmental Characteristics in Female Veterans With and Without Cholelithiasis.  
 
 
With Cholelithiasis 
(n= 242) 
 
Without Cholelithiasis 
(n=242) 
Characteristics n % 
 
n % 
      
 
Military branch 
     Army 50 20.66 
 
14 5.79 
Air Force 19 7.85 
 
10 4.13 
Navy 20 8.26 
 
7 2.88 
Marine Corp 7 2.89 
 
2 0.82 
Other(>2 branch) 2 0.83  1 0.41 
Unknown 144 59.50 
 
208 85.95 
Total 242 100  242 100 
    
     Military Service (months) 95 39.26
 
34 14.05
Unknown 147 60.74 208 85.95 
Total 242 100  242 100 
Warzone exposure 1 0.41 
 
0 0 
Unknown 241 99.59  242 100 
Total 242 100  242 100 
   
 
  
 
A majority of female veterans in both groups served in the Army, with 51.6% of female 
veterans in the cholelithiasis group and 26.9% in the group without cholelithiasis. Female 
veterans who served in the Navy had the second highest percentage of cholelithiasis (20.41%) 
representing the third highest percentage of female veterans without cholelithiasis (13.46%). Air 
Force female veterans had the third highest percentile of cholelithiasis (19.39%) and the second 
highest percentage of female veteran without cholelithiasis (19.23%).  
Comparison of the service branch served by female veterans is displayed in Figure 6.  
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Figure 6. Military branches served by female veterans with and without cholelithiasis. 
 
The length of military service was based on months of service. Military service was 
longer in females with cholelithiasis (M=38.94, SD=51.73) than those without cholelithiasis 
(M=28.24, SD=17.21) although the difference between the two groups was not statistically 
significant (t = 1.18, p = .24). Mean military disability status was similar between two groups 
with cholelithiasis (M=33.87, SD=22.22) and without cholelithiasis (M=36.17, SD=31.05). There 
was no significant difference between two groups (t = -.55, p= .59) as shown in Table 8.   
Table 8. Mean of Environmental Factors in Female Veterans With and Without Cholelithiasis. 
 
     
   M  SD   t   p 
     
 
Military Service (months) 
    
 Cholelithiasis 38.94 51.73 1.18 0.24 
 No-cholelithiasis 28.24 17.21   
 
Military Disability (%)     
 Cholelithiasis 32.86 22.22 0.55 0.59 
 No-cholelithiasis 36.17 31.05   
 
Note.
 *
p ≤ 0.05, ** p ≤ 0.01 
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Military disability status is closely tied to the treatment and care plans for military 
veterans in the VHA. Military disabilities are the result of a disease or injury that occurred 
during active military service. The disability status is recoded as a percentage in the VHA and it 
was examined as such in this study. Total percentage of military disability status for patients was 
included with varied ranges from 10 to 100%. More numbers of female veterans with 
cholelithiasis had military disability status (n=65) than females without cholelithiasis (n=23). 
Total percentage of disability status was higher in females with cholelithiasis than those without 
cholelithiasis although the difference was not statistically significant (t
 
= .55, p = .59). Figure 7 
presents comparisons of the military disability status in both groups. 
 
Figure 7. Numbers of military female veterans with and without cholelithiasis and their 
percentage of disabilities. 0% of disability was listed to show there were no female veterans who 
had disability rate between 0% to 10%. The minimum disability in this study was reported as 
10% and maximum was reported as 100%. 
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The most common cause of disability status for female veterans with cholelithiasis was 
posttraumatic stress disorder (n=27). Bipolar disorder (n=6), migraine headache (n=6), and 
degenerative arthritis of sprain (n=5) were also frequent reasons for disability status in females 
with cholelithiasis. Degenerative arthritis, hypertensive vascular disease, knee condition, and 
lumbosacral or cervical strains were the most common causes of disabilities in females without 
cholelithiasis. The disability conditions are reported for both groups in Table 9.  
Table 9.  The Most Common Types Of Disabilities Causes in Female Veterans With and Without 
Cholelithiasis.  
 
With Cholelithiasis 
 
Without Cholelithiasis 
Causes 
 
n 
 
% 
 
 Causes 
 
n 
 
% 
 
 
Posttraumatic disorder 27 11.16 
 
Degenerative-arthritis 4 1.65 
Bipolar disorder 6 2.48 
 Hypertensive-vascular 
disease 4 1.65 
Migraine headache 6 2.48  Knee condition 3 1.24 
Degenerative-arthritis of 
spine 4 1.65 
 Lumbosacral or –cervical 
strain  3 1.24 
Major depressive-disorder 3 1.24  Paralysis of – sciatic nerve 2 0.83 
Knee prosthesis 3 1.24  Limited knee flex 2 0.83 
No disability reported 193 79.75  No disability reported 224 92.56 
Total 242 100  Total  242 100 
       
 
The military veteran population has been known to have higher alcohol and tobacco 
consumption levels compared to civilians (Park et al., 2011). However, many studies do not 
include female veterans. Data from this study showed that tobacco use was significantly higher 
(X
2
 = 16.3, p < .01) in females with cholelithiasis (16.94%) than those without cholelithiasis 
(5.37%). Also, the difference was statistically significant for an increased risk for cholelithiasis. 
More female veterans with cholelithiasis (4.55%) indicated that they used alcohol in comparison 
to the female veterans without cholelithiasis (1.65%). However, no statistical significance 
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(X
2 
=3.37, p = .07) was found. As shown in Table 8, use of female hormones was not 
significantly different in females with and without cholelithiasis (X
2
= 1.82, p = .18). The use of 
alcohol, tobacco, and hormone replacement for female veterans with and without cholelithiasis is 
listed in Table 10. 
Table 10.  Frequency of Alcohol, Tobacco, and Hormone Use in Female Veterans With and 
Without Cholelithiasis. 
 
     
               n           %             X
2
        p 
     
 
Use of Alcohol 
    
 Cholelithiasis 11 4.55 3.37     0.07 
 No-cholelithiasis 4 1.65  
 
 
Use of Tobacco     
 Cholelithiasis 41 16.94 16.34 0.00** 
 No-cholelithiasis 13 5.37 
 
  
Use of Female hormone     
 Cholelithiasis 1 0.41 1.82      0.18 
 No-cholelithiasis 4 1.65  
 
 
Note.
 *
p ≤ 0.05, ** p ≤ 0.01 
 
Specific Aim 2 
Aim 2. Examine differences among metabolic, liver enzyme and serum lipid laboratory data in 
female military veterans with and without cholelithiasis.  
The serum laboratory tests used in this study were serum metabolic, liver enzymes and 
lipid profile laboratory data. Individual test values were compared to female veterans with and 
without cholelithiasis using independent sample t tests.  
Differences between serum metabolic levels in female veterans with and without 
cholelithiasis. Diabetes is reported to be highly related to cholelithiasis development (De Santis, 
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et al., 1997; Gielkens et al., 1998; Haffner, Diehl, Mitchell, Ruhl and Everhart, 2000; Shaw et al., 
1993; Stern, & Hazuda, 1990). Hemoglobin A1C (HbA1C) and fasting glucose levels are widely 
used to identify diabetes (American Diabetes Association, 2010; Goldstein et al., 2004; Nathan et 
al., 2008; World Health Organization, 2006). In this study, females with cholelithiasis (M= 7.41, 
SD= 1.67) had a higher mean hemoglobin A1C value than those without cholelithiasis (M= 6.09, 
SD= .92) and the difference was statistically significant (t = 7.33, p < .01). Mean fasting glucose 
concentration was not significantly different in females with and without cholelithiasis (t=1.86, 
p = .08). The mean comparison of serum metabolic values is displayed in Table 11.  
Table 11.  Mean Serum Metabolic Laboratory Levels in Female Veterans With and Without 
Cholelithiasis. 
 
      
Variable  n M SD t p 
      
      
Glucose      
 Cholelithiasis 228 112.10 48.99 1.86 0.08 
 No-cholelithiasis 147 103.80 
 
   
HbAIC      
 Cholelithiasis 213 7.41 1.67 7.33 0.00** 
 No-cholelithiasis   97 6.09 0.92 
 
  
Note.
 *
p ≤ 0.05, ** p ≤ 0.01. HbA1c= Hemoglobin A1c. 
 
Differences among liver enzymes in female veterans with and without Cholelithiasis. 
Liver enzymes of bilirubin, aspartate transaminase (AST) and alanine transaminase (ALT) were 
compared in female veterans with and without cholelithiasis. No significant differences were 
found in AST (t = 1.25, p = .21) and ALT levels (t = .33, p = .75) between females with and 
without cholelithiasis. In addition, there were no significant differences in bilirubin levels (t = 
58 
.56, p = .57) between the two groups of females. The mean compared the two groups to serum 
liver enzymes are reported in Table 12.  
Table 12.  Mean Comparisons of Liver Enzymes in Female Veterans With and Without 
Cholelithiasis. 
 
      
Variable  n M SD t p 
      
      
Total bilirubin      
 Cholelithiasis 226 0.58 0.46 0.56 0.57 
 No-cholelithiasis 133 0.55 0.23 
 
  
AST      
 Cholelithiasis 213 28.30 34.87 1.25 0.21 
 No-cholelithiasis 137 24.49 9.29 
 
  
ALT      
 Cholelithiasis 228 26.41 20.89 0.33 0.75 
 No-cholelithiasis 149 25.80 11.43 
 
  
Note.
 *p ≤ 0.05, ** p ≤.0.01, AST= Aspartate Transaminase, ALT= Alanine Transaminase 
 
Differences among lipid profile in female veterans with and without cholelithiasis. 
Lipid profiles for total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein 
(LDL) and triglycerides were examined between female veterans with and without cholelithiasis. 
Total cholesterol was significantly higher (t =4.34, p < .01) and HDL values were significantly 
lower (t = -4.27, p < .01) in females with cholelithiasis. The levels of LDL and Triglycerides 
were not statistically significant when comparing the female veterans with and without 
cholelithiasis. Mean comparisons of serum lipids levels in both groups are displayed in Table 13. 
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Table 13.  Mean Comparison of Serum Lipids in Female Veterans With and Without 
Cholelithiasis. 
 
      
Variable  n M SD t p 
      
Total cholesterol      
 Cholelithiasis 242 123.69 65.82 4.34 0.00** 
 No-cholelithiasis 227 98.72 58.40  
 
 
HDL      
 Cholelithiasis 177 47.13 17.29 -4.27 0.00** 
 No-cholelithiasis 107 56.28 17.90   
 
LDL      
 Cholelithiasis 127 106.61 38.26 0.88 0.38 
 No-cholelithiasis 91 101.94    
 
Triglycerides      
 Cholelithiasis 239 153.23 74.91 1.62 0.11 
 No-cholelithiasis 216 140.60 79.19   
 
Note.
 *
p ≤ 0.05, ** p ≤ 0.01, HDL= high density lipoprotein cholesterol, LDL = low density 
lipoprotein cholesterol 
 
Values of serum total cholesterol are categorized as normal (below 200 mg/dl), borderline 
(between 200-239 mg/dl) and at risk (above 240mg/dl) (National cholesterol education program, 
2001). Although mean levels of total cholesterol in both groups were in a normal range, females 
with cholelithiasis had higher total cholesterol levels (M=124 mg/dl, SD= 65.82), than those 
without cholelithiasis (M= 98.72 mg/dl, SD=58.40). Serum cholesterol differences in female 
veterans with and without cholelithiasis group were statistically significant (t = 4.34, p < .01).  
Levels of HDL were significantly lower in females with cholelithiasis (M= 47.12, SD= 
17.29) than those without cholelithiasis (M=56.28, SD=17.90). The HDL differences between 
female veterans with and without cholelithiasis were statistically significant (t=-4.27, p < .01). 
The desired HDL level is > 40 mg/dl (National cholesterol education program, 2001). 
60 
Specific Aim 3 
Aim 3. Explore differences between diagnosed metabolic and biliary comorbidities experienced 
by female military veterans with and without cholelithiasis.  
Statistical differences in the comorbid conditions experienced by female veterans with 
and without cholelithiasis were examined using chi-square statistics. 
Differences of biliary comorbidities in female veterans with and without 
cholelithiasis. There were no significant differences in hepatitis B presence in females with and 
without cholelithiasis. Fourteen females in cholelithiasis group had a history of hepatitis C in 
comparison to one female in the no-cholelithiasis group. The difference between the two groups 
was statistically significant (X
2 
= 11.63, p < .01). The frequency of liver cirrhosis was also higher 
in females with cholelithiasis (n= 13, 5.37%) than those without cholelithiasis (n=0) and the 
difference was statistically significant (X
2
 =13.36, p < .01). The comparison of liver diseases 
between females with and without cholelithiasis is reported in Table 14.   
Table 14.  Comparison of Biliary Comorbidities in Female Veterans With and Without 
Cholelithiasis. 
 
     
 n    % X
2
 p 
     
     
Hepatitis B     
 Cholelithiasis 2 0.83 2.01 0.16 
 No-cholelithiasis 0 0  
 
 
Hepatitis C      
 Cholelithiasis 14 5.79 11.63 0.00** 
 No-cholelithiasis 1 0.41   
 
Liver Cirrhosis     
 Cholelithiasis 13 5.37 13.36 0.00** 
 No-cholelithiasis 0 0   
 
Note.
*
p = < .05, 
** 
p = < .01, df =482 
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Differences of metabolic comorbidities in female veterans with and without 
cholelithiasis. Female veterans with cholelithiasis had higher prevalence of diabetes (n= 57, 
23.55%) and the differences between two groups were statistically significant (X
2
 =28.78, p < 
.01). The prevalence of dyslipidemia was also higher in females with cholelithiasis (n= 86, 
35.53%) and the differences were statistically significant (X
2
 = 35.56, p < .01). The prevalence of 
hypertension was also higher in females with cholelithiasis (n=102, 42.15%) than those without 
cholelithiasis (n=38, 15.70%), and the difference reached statistical significance (X
2
 = 41.16, 
p < .01). Although Crohn’s disease is an autoimmune disease, it was classified as a metabolic 
comorbidity for convenient analyses. However, only three females had Crohn’s disease, two with 
cholelithiasis and one without. There was no significant difference between female veterans with 
and without cholelithiasis and Crohn’s disease. (X2= .34, p > .05). The comparison of metabolic 
diseases in females with and without cholelithiasis is displayed in Table 15. 
Table 15.  Comparison of Metabolic Comorbidities in Female Veterans With and Without 
Cholelithiasis. 
 
     
Variable  n % X
2
 p 
     
     
Diabetes     
 Cholelithiasis 57 23.55 28.78 0.00** 
 No-cholelithiasis 15 6.20   
 
Dyslipidemia     
 Cholelithiasis 86 35.53 35.56 0.00** 
 No-cholelithiasis 30 12.40   
 
Hypertension      
 Cholelithiasis 102 42.15 15.70 0.00** 
 No-cholelithiasis 38 15.70   
 
Crohn’s Disease     
 Cholelithiasis 2 0.83 0.34 0.56 
 No-cholelithiasis 1 0.41   
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Note.
 *
p = < 0.05, 
** 
p = < 0.01, df =482 
 
 
Differences among other comorbidities of female veterans with and without 
cholelithiasis. Female veterans with cholelithiasis were more frequently diagnosed with 
posttraumatic stress disorder (PTSD) than females without cholelithiasis (X
2
 =12.62, p < .01). 
Military sexual trauma (MST) was also found more frequently in female veterans with 
cholelithiasis (n=32, 13.22%) than female veterans without cholelithiasis (n= 7, 2.89%). The 
significant differences are shown in Table 16. 
Table 16.  Comparison of Other Comorbidities in Female Veterans With and Without 
Cholelithiasis. 
 
     
Variable  n % X
2
 p 
     
     
PTSD     
 Cholelithiasis 32 13.22 12.62 0.00** 
 No-cholelithiasis 10 4.13   
 
MST     
 Cholelithiasis 32 13.22 17.43 0.00** 
 No-cholelithiasis 7 2.89   
 
Note. 
*
p = < 0.05, 
** 
p = < 0.01.df =482.  PTSD= Posttraumatic stress disorder, MST=Military 
sexual trauma  
 
Overall frequencies of comorbidities were higher in female veterans with cholelithiasis 
than those without cholelithiasis. The comparison by frequencies is shown in Figure 8. 
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Figure 8. Overall frequency of comorbidities in female veterans with and without cholelithiasis. 
** Statistically significant by Chi-square tests. 
Specific Aim 4 
Aim 4. Explore associations among demographic, environmental, laboratory data and diagnosis 
of comorbid conditions among female military veterans with and without cholelithiasis 
After examining the independent risk factors of female veterans with and without 
cholelithiasis, the associations of variables related to cholelithiasis were explored using 
Pearson’s correlation coefficients. Inter-correlations of study variables were analyzed and are 
displayed in Table 16. Age and BMI have major contributing factors for developing 
cholelithiasis (Shaffer, 2006; Volzke et al., 2005). However age and BMI in this study were not 
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significantly related to cholelithiasis presence. Similarly, female hormone therapies due to 
postmenopausal syndrome have reported a close relationship to cholelithiasis development but 
this study showed no significant relationship with cholelithiasis (Angelin et al., 1992;  
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Henriksson, Einarsson, Eriksson, Kelter, Angelin, 1989; Maurer, Everhart, Knowler, Shawker, & 
Roth, 1990; Scragg, McMichael, & Seamark, 1984). Alcohol use, military service, and disability 
status were not significantly associated with cholelithiasis occurrence. Tobacco use was 
significantly associated with cholelithiasis occurrence (r = 0.18, p < .01). Lipids have been 
reported as a controversial factor in relation to cholelithiasis because of inconsistent study 
findings. Total cholesterol (r= 0.20, p< .01) and hemoglobin A1C (r= 0.39, p< .01) in this study 
were significantly positively related to cholelithiasis. A significant negative interaction was also 
found between serum high density lipoprotein (HDL) and cholelithiasis occurrence (r= -0.25, 
p < .01).  
Associations of demographic and environmental factors in relation to cholelithiasis. 
A step-wise multiple logistic regression analysis was performed to identify the most significant 
risk factors related to cholelithiasis occurrence. Tobacco use was the only significant association 
among demographic and environmental factors to cholelithiasis occurrence. The study 
calculation showed that the likelihood of having cholelithiasis was 3.15 times greater in female 
veterans with a smoking habit than females without a smoking habit (OR=3.15, p < .01). 
Associations of serum laboratory values related to cholelithiasis. Variables were 
analyzed using a linear stepwise regression. Correlational analysis to determine the likelihood of 
developing cholelithiasis was analyzed using a linear stepwise regression. A stepwise regression 
was used to maximize the prediction in relation to cholelithiasis occurrence. In a step 1 of 
analysis, hemoglobin A1C was entered in the regression equation and was significantly related to 
cholelithiasis occurrence (R
2
= .14, p< .01). HDL was then entered into the equation as the second 
step. Hemoglobin A1C and HDL together increased the significance of cholelithiasis occurrence 
(R
2
= .23, p < .01). Total cholesterol was entered as the third step, and the equation showed an 
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increased prediction for cholelithiasis (R
2
= .26, p < .05). Results show as each risk factor was 
added, the likelihood of cholelithiasis occurrence increased. This indicates that 26% of the 
variance in predicting the likelihood of having cholelithiasis that was accounted by hemoglobin 
A1C, HDL, and total cholesterol. Results of the stepwise regression are presented in Table 18. 
Table 18.  Linear Stepwise Regression in Serum Laboratory Values Associated With 
Cholelithiasis. 
 
       
Model Variable R
2
 Adjusted R
2
 R
2 
change Standardized β Sig. 
       
       
Step 1 HbA1C .14 .13 .14 .38 0.00** 
       
Step 2 HbA1C    .32  
 HDL .23 .21 .08 -.30 0.00** 
       
Step 3 HbA1C    .32  
 HDL    -.32  
 Cholesterol .26 .24 .04 .20 0.02* 
 
Note.
 *
p = <0 .05, 
** 
p = <0 .01. HbA1C=Hemoglobin A1C, HDL=High- density lipoprotein, 
Cholesterol= total cholesterol. 
 
Associations of the significant diagnosed comorbidities (hypertension and hepatitis 
C) related to cholelithiasis. Of the comorbidities, only hypertension and hepatitis C were 
included in a stepwise model. These were the only variables that had significant Chi-square test 
differences while controlling confounding effects. Since none of the independent variables in the 
analysis had a standard error larger than 2.0, there was no evidence of multicollinearity between 
independent variables. This model was statistically significant with an overall χ2a=51.02, 
Nagelkerke’s R2 = .13, and p < .01. The results indicate that female veterans with hypertension 
had 2.68 times the relative risk of developing cholelithiasis (95% CI= 1.69 to 3.59) in 
comparison to those who did not have hypertension. Also, female veterans with hepatitis C had 
8.34 times higher relative risk (95% CI=1.07 to 64.77) compare to who did not have the disease. 
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The relationships between the diagnosed comorbidities and cholelithiasis are reported in Table 
19. 
Table 19.  Logistic Stepwise Regression Analysis of Diagnosed Comorbidities Associated With 
Cholelithiasis. 
 
       
             95% C.I. for Odds 
  Comorbidities   B SE p Odds Lower Upper 
        
        
Step 1 HTN 0.99 0.19 
 
0.00** 2.68 1.85 3.9 
        Step 2 HepC 2.12 1.05 0.04* 8.34 1.07 64.77 
 
HTN 0.9 0.19 
 
0.00** 2.46 1.69 3.59 
        
Note.  Overall Model χ2a=51.02 with a Nagelkerke pseudo R Square =0.134, and p<0.001, with 
an overall change in model accuracy from 50% to 63.8%. 
 
Summary  
The purpose of this study was to identify the relationship among demographic and 
environmental factors, serum lipid and liver enzyme concentrations, and associated 
comorbidities to increased risk for cholelithiasis occurrence among female veterans. 
Although many studies have reported a significant relationship among age, race, BMI and 
cholelithiasis occurrence (Everhart et al., 2002; Shaffer, 2005; Torgerson, Lindroos, Naslund, & 
Peltonen, 2003; Tsai, Leitzmann, Willett, & Giovannucci, 2004), this study did not find the same 
significant relationships. This study indicated tobacco use to be significantly related (p< .01) to 
the risk for cholelithiasis. Among the serum laboratory tests, mean serum cholesterol (p< .01) 
and hemoglobin A1C were positively associated with cholelithiasis while low HDL levels were 
significantly associated (p< .01) with an increased risk for cholelithiasis occurrence. The 
comorbid conditions of diabetes, dyslipidemia, hepatitis C, liver cirrhosis, hypertension, 
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posttraumatic stress disorder, and military sexual trauma occurred more frequently in female 
veterans with cholelithiasis than females without cholelithiasis. However, only hypertension and 
hepatitis C (p < .05) reached statistical significance while controlling confounding variables.  
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CHAPTER V 
 
DISCUSSION 
 
The purpose of this study was to identify the relationship between predisposing risk 
factors and cholelithiasis occurrence in military female veterans. The specific aims for the study 
were: 1) Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis; 2) Examine differences among metabolic, liver enzyme 
and serum lipid laboratory data in female military veterans with and without cholelithiasis; 3) 
Explore differences between diagnosed metabolic and biliary comorbidities experienced by 
female military veterans with and without cholelithiasis; 4) Explore associations among 
demographic, environmental, laboratory data and diagnosis of comorbid conditions among 
female military veterans with and without cholelithiasis.  
 In the next section, conclusions and suggestions for each aim of this study were reviewed 
and the relation to literature was discussed. In addition, nursing implications, future research 
recommendations, methodological consideration, and limitation were presented. Results of the 
specific aims that are discussed in the chapters are as follow:  
Specific Aim 1 
Aim 1. Determine the demographic and environmental characteristics of female military 
veterans with and without cholelithiasis 
The data did not support the differences of demographic and environmental 
characteristics in military female veterans with cholelithiasis occurrence. Factors including age, 
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Body Mass Index (BMI), and ethnicity in demographics were not significantly different in 
female veterans with and without cholelithiasis and no association was found with cholelithiasis. 
When considering environmental factors, length of military services and percentage of disability 
status were not significantly different in female veterans with and without cholelithiasis. In 
addition, use of alcohol and hormone replacement therapy were also not associated with 
cholelithiasis occurrence.  
Tobacco use, on the other hand, was significantly associated with cholelithiasis. Female veterans 
who had a history of tobacco use had an increased risk for developing cholelithiasis.  
Demographic Factors 
Female gender (estrogen hormone use) and gallstones. This study only included 
females. The female gender is a significant risk factor for cholelithiasis development, yet no 
study was found to identify the risk of cholelithiasis occurrence in military female veterans. 
Females are almost twice as likely to develop gallstones (Everhart, Khare, Hill, & Maurer, 1999; 
Nakeeb et al., 2002) and more likely have a cholecystectomy compared with male population 
(Acalovschi, 2001). The different prevalence between men and women begins to narrow 
following menopause (Shaffer, 2005). Estrogen is a contributor, therefore parity, oral 
contraceptive use and estrogen replacement therapy are reported to be risk factors for 
cholelithiasis (Cirillo et al., 2005; Hulley et al., 1998; Thijs & Knipschild, 1993).  
This study identified no relationship between the hormone replacement therapy and 
contraceptives, but showed a slight but insignificant negative association. Several studies have 
indicated there is a significant association between hormone replacement therapy (Angelin et al., 
1992; Henriksson, Einarsson, Eriksson, Kelter, Angelin, 1989; Maurer, Everhart, Knowler, 
Shawker, & Roth, 1990), contraceptives (Scragg, McMichael, & Seamark, 1984) and 
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cholelithiasis occurrence whereas some studies have not found a positive relationship (Barbara et 
al., 1987). A randomized, double-blinded, placebo-controlled study suggested a greater risk to 
cholelithiasis, cholecystitis, and gallbladder surgeries in women aged 50 to 79 years with 
estrogen therapy (Cirillo, 2005). Another large prospective cohort study supported women 
receiving with oral estrogens alone had a greater risk for cholelithiasis as well as 
cholecystectomy than women receiving with oral estrogens combined with a progestagen 
(Racine et al., 2013). Although the effect of estrogen in relation to cholelithiasis development is 
not fully understood it is believed that estrogen can cause increased excretion of cholesterol into 
bile (Sanders & Kingsnorth, 2007) and diminish bile salt secretion, thus contributes 
supersaturation (Acalovschi, 2001) that leads to stasis.  
This study did not support the findings of previous studies likely because of a small 
sample size. The sample size for this study was 484 in comparison to previous studies of 22,579 
menopausal women (Cirillo et al, 2005) and 70,928 menopausal women (Racine et al., 2013). In 
this study, only one female veteran used hormone replacement therapy in the cholelithiasis group 
and four in the no-cholelithiasis group. Further, these investigators speculated that the 
relationship between female hormone therapy and cholelithiasis occurrence might be dose-
dependent. A short time use or low dose of estrogen use may be associated with a lower risk for 
cholelithiasis development (Cirillo et al., 2005). This factor was identified in a study by Hulley et 
al. (1998) in a randomized trial during which post-menopausal women who were taking 0.625 
mg of conjugated estrogens and 2.5 mg of medroxyprogesterone acetate had an increased risk of 
gallbladder disease compared to a placebo group during a 4 year follow-up. Another randomized 
placebo-controlled trial of the Women’s Health Initiative supported that menopausal women who 
used 0.625 mg of estrogen had a greater risk of gallbladder disease or surgery (Cirillo et al., 
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2005). The types, dose and length of the hormone therapy or contraceptives were not included in 
this study. Additional research may be needed to investigate the effect of hormone replacement 
therapy and contraceptives use including types, dose, and length of the therapy with a bigger 
sample size in relation to cholelithiasis in military female veterans.  
Age and gallstones. Approximately 40% of the female veterans in the VHA system are 
under the age of 40 years and about 60% of female veterans are older than 44 years.  
(http://www.va.gov/vetdata/docs/SpecialReports/Women_Veteran_Profile5.pdf, 2013). The 
median age of military female veterans in the US is 49 years 
(http://www.va.gov/vetdata/docs/SpecialReports/Women_Veteran_Profile5.pdf, 2013). 
The mean age of women in this study was 58 due to the fact that this study included only females 
veterans aged over 40 years old. Previous studies have reported the prevalence of cholelithiasis 
increases with age, especially in age groups of women over 40 and the increased risk becomes 4 
to 10 times more than females aged younger than 40 years (Shaffer, 2006). A prospective 
ultrasound-sonographic study supported the risk for developing cholelithiasis increases with age 
(Chen, 1998). Older female patients present more symptomatic gallstone diseases and as a result, 
have more cholecystectomies (Shaffer, 2006; Volzke et al., 2005). In this study, 47.6% of female 
veterans with cholelithiasis were aged 50-60 (47.6%). The studies indicate that during an 
abdominal work up, cholelithiasis also should be considered in the differential diagnosis, 
especially in women aged 45-60.  
Ethnicity and gallstones. It is reported that about 33% of female veterans are considered 
a racial minority (any racial group other than white) (Census Bureau, 2011). Demographics in 
the VHA have shown female veterans consist of Caucasian  (67%), African American (20.1%), 
Hispanic (7.8%), Asian and Native Hawaiian or Pacific Islander (1.8 %), American Indian or 
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Alaska Native (0.7%), and two or more races (2.7%) (Census Bureau, 2011). The ethnicity of 
female veterans with cholelithiasis presented in a similar pattern as the veteran distribution of the 
general VHA, as follows: Caucasian (69%), African American (27.3%), American Indian or 
Alaska Native (0%), Asian (.4%), Native Hawaiian or Pacific Islander (1.7%) and unknown 
(1.7%). The result of this study revealed no significant relationship between different ethnicity in 
female veterans and cholelithiasis occurrence.  Previous studies identified ethnicity as an 
independent risk factor for cholelithiasis development. Prevalence studies have demonstrated 
North American Indians as having the highest reported rate of cholelithiasis development, 
affecting 64.1% of women and 29.5% of men (Everhart et al., 2002; Shaffer, 2005).  
Body weight and gallstones. Women with severe obesity (BMI > 32 kg/m
2
) are six 
times more likely to develop gallstones compared to non-obese controls (Maclure, Hayes, 
Colditz, Stampfer, Speizer, & Willett, 1989). The same study indicated that the annual chance of 
developing gallstones was about 2% in obese women (Maclure, Hayes, Colditz, Stampfer, 
Speizer, & Willett, 1989). This study supported the previous findings as a higher BMI (M= 
31.64, SD= 7.30) was found in female veterans with cholelithiasis although the difference was 
not statistically significant.  
Previous studies have demonstrated that obesity is a major factor for cholelithiasis 
occurrence, especially in females (Heaton, 1991; Everhart & Khare, 1999; Attili, 1997, 
Friedman, Kalel, & Dawber, 1996). This may be due to an increased hepatic secretion of 
cholesterol (Shaffer & Small, 1977) relative to a decrease in phospholipids and bile salts, 
creating supersatulation with cholesterol (Acalovschi, 2001; Angelico, Del Ben, Barbato, Conti, 
Urbinati, 1997; Amaral & Thompson, 1985; Apstein & Carey, 1996; Shaffer & Small, 1977) that 
can lead to gallstone formation. Several studies have shown a positive relationship with BMI 
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(Angelico, Del Ben, Barbato, Conti, & Urbinati, 1997; Attili et al., 1997; Chen et al., 1998; 
Mendiz-Sanchez, Vega, Uribe, Guevara, Ramos, & Vargas- Vorackova, 1998; Torgerson, 
Lindroos, Naslund, & Peltonen, 2003; Tsai, Leitzmann, Willett, & Giovannucci, 2004;), 
although some did not find the relationship (Janzon, Aspelin, Eriksson, Hildell, Trell, & Ostberg, 
1985; Thijs, Knipschild, & Leffers, 1992). 
The limitation of this study was the use of BMI as a measurement of obesity.  
More recent studies have found waist circumference and waist-to-hip ratio both to be better 
indicators obesity compared to BMI alone (Everhart et al., 2002; Tsai, Leitzmann, Willett, & 
Giovannucci, 2004). Some studies have supported abdominal adiposity as significantly 
correlated with cholelithiasis occurrence, especially in the female population (Everhart et al., 
2002; Hartz, Rupley, & Rimm, 1984; Maclure et al., 1989; Tsai, Leitzmann, Willett, & 
Giovannucci, 2004). This suggests that waist circumferences and waist-to-hip ratio with BMI 
should be included in measuring obesity, especially in females. Additional studies are 
recommended while taking into account the diverse measurement for obesity in relation to 
cholelithiasis occurrence in military female veterans.  
Environmental Factors  
Military occupational factors and gallstones. This study did not find a significant 
relationship between military occupational factors and cholelithiasis occurrence among female 
veterans, except PTSD and MST that were discussed under comorbid conditions. Studies did not 
support the relationship between military occupational factors and cholelithiasis occurrence. 
Length of military services was longer in females with cholelithiasis than those without 
cholelithiasis but the difference was not significant. The branch of services was also not related 
75 
to cholelithiasis occurrence. The most common branch served by the study population with and 
without cholelithiasis was the Army followed by the Air Force and Navy.  
A study reported male veterans with PTSD associated with warzone exposure were found 
to have abnormal lipids values (Karlovic, Buljan, Martinac, & Marcinko, 2004). However, 
female veterans were not included in this study. Another study reported PTSD was highly 
associated with abnormal lipids levels (Kagan, 1999). Many scientific studies have also 
demonstrated a strong association with abnormal serum lipid levels in people with cholelithiasis 
(Andreotti, 2008; Atamanalp et al., 2013; Fu, Gong, & Shao, 1995; Halldestam, Kullman, & 
Borch, 2009; Khairy et al., 2004; Tang, 1996; Thijs, Knipschild, & Brombacher, 1990). This 
study identified whether the warzone exposure in female veterans was associated with 
cholelithiasis occurrence. However, there was only one female with cholelithiasis who was 
exposed to warzone. Military disability is a major gateway to accessing healthcare in the VHA 
system. The mean percentage of disability status was slightly higher in female veterans with 
cholelithiasis than those without cholelithiasis. However the relation between military disability 
status and increased risk for cholelithiasis was not found in this study.   
Alcohol use and gallstones. This study was not able to define the impact of alcohol use 
on cholelithiasis. There was no significant difference in females with and without cholelithiasis 
in relation to alcohol use. The literature has reported an inverse association between alcohol 
intake and cholelithiasis occurrence (Attili, Scafato, Marchioli, Marfisi, & Festi, 1998; 
Leitzmann et al., 1999; Leitzmann et al., 2003; Volzke et al, 2005; Walcher et al., 2010), 
although some studies have failed to find any relationship (Basso, McCollum, Darling, Tocchi, 
& Tanner, 1992; Kratzer et al., 1997; Pixley & Mann, 1988; Sahi, Paffenbarger, Hsieh, & Lee, 
1998).  
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Volzke et al. (2005) demonstrated relative risks of daily amount of alcohol consumption 
being associated with cholelithiasis. The findings of this study showed that men who consumed 
daily alcohol intakes of more than 60 grams had a significantly lower risk of developing 
cholelithiasis in comparison to men who consumed less daily alcohol. Studies that included both 
men and women also supported similar outcomes that frequent moderate alcohol consumption 
was associated with a lower risk for cholelithiasis occurrence (Leitzmann, et al., 2003; Thornton, 
J., Symes, C., & Heaton, K, 1983). The risk of cholelithiasis increases in severe alcohol abuse 
because of damage to the liver and reduced bile salt synthesis (Fornari et al., 1994; Poynard et 
al., 1995). 
These studies supported a hypothesis that alcohol consumption may inhibit cholesterol 
stone formation by reducing the cholesterol saturation, raising bile salts (Nestel, Simons, & 
Homma, 1976; Yoshida, McCormick, Swell, & Vlahcevic, 1975) and increasing HDL 
concentration (Gaziano et al., 1993; Rakic, 1998; Thornton, Symes, & Heaton, 1983). Overall 
US military veterans are reported to have higher alcohol consumption and higher prevalence of 
alcohol-related medical problems (Park, 2011) in comparison to male civilians. Unfortunately, 
studies related to the same issue among female veterans are limited. 
Tobacco use and gallstones. The finding of this study revealed a significant relationship 
between tobacco use and cholelithiasis occurrence in female veterans. Females with tobacco use 
were 3 times more likely to develop cholelithiasis compared to females who indicated that they 
did not smoke. Literature was not clear whether or not tobacco use increases the risk of 
cholelithiasis occurrence. Some studies reported that smokers have a lower tendency to develop 
cholelithiasis due to a mechanism involving decreased prostaglandin synthesis and mucus 
production in the gallbladder epithelium (Lindstrom, 1977). However, another study has drawn 
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the opposite conclusion that heavy smoking (more than 35 cigarettes per day) was an 
independent risk factor for cholelithiasis occurrence among women (Stampfer, Maclure, Colditz, 
Manson, & Willett, 1992). A large-scale population-based study of women supported smoking as 
an important risk factor for developing symptomatic gallstone disease (Murray, Logan, 
Hannaford, & Kay, 1994).  
Specific Aim 2 
Aim 2. Examine differences among metabolic, liver enzyme and serum lipid laboratory data in 
female military veterans with and without cholelithiasis 
The findings of this study supported the relationship between serum metabolic levels and 
increased risks for cholelithiasis. Female veterans with cholelithiasis had a significantly higher 
hemoglobin A1C (HbA1C) levels than female veterans without cholelithiasis. The difference 
was significant but no difference was found in serum fasting glucose level. HbA1C was one of 
the most significant independent indicators to predict cholelithiasis in this study.  
There was no association found between serum liver enzyme levels and cholelithiasis 
among female veterans. Pearson Correlation analysis in this study indicated that AST, ALT and 
bilirubin were not associated with cholelithiasis occurrence although they are known to be an 
effective predictor for liver damage (Kaplan, 2002; Tung et al., 2006), especially in patients with 
hepatitis C and liver cirrhosis (Sheth, Flamm, Gordon, & Chopra, 1998).  
Partial support was found for the link between serum lipid levels and cholelithiasis 
among female veterans. High total serum cholesterol levels and low HDL levels were 
significantly associated with cholelithiasis. LDL cholesterol and triglycerides levels were not 
statistically different in females with and without cholelithiasis. 
Metabolic Tests (Fasting glucose and Hemoglobin A1C) and Gallstones 
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Serum fasting glucose levels are widely used as a diagnostic criterion for diabetes 
(American Diabetes Association, 2010; World Health Organization, 2006). Many studies have 
indicated the close association between diabetes and increased risk for cholelithiasis (De Santis, 
et al., 1997; Gielkens et al., 1998; Haffner, Diehl, Mitchell, Stern, & Hazuda, 1990; Shaw et al., 
1993), yet serum fasting glucose levels are not commonly evaluated. Previous studies reported 
that hyperglycemia contributed to reduction of bile secretion from the liver by increasing 
cholesterol concentration, this then decreases gallbladder motility and leads to gallstone 
formation (DeBoer, Masclee, & Lamers 1992; Leon, Ferenderes, & Carulli, 1978). Another 
studies have indicated patients with gallstones had further complications of hyperglycemia and 
autonomic neuropathy in comparison to patients without gallstones (Fiorucci et al., 1990; Hahm 
et al., 1996). 
Findings of this study indicated that female veterans with higher hemoglobin A1C levels 
also had a higher risk of developing cholelithiasis in comparison to females with normal 
hemoglobin A1C values. American Diabetes Association (2010) defines the normal value of 
hemoglobin A1C as less than 5.7%. The mean hemoglobin A1C level in female veterans with 
cholelithiasis was 7.41% and 6.09% in those without cholelithiasis. Some studies argue 
hemoglobin A1C is a better tool to identify a patient’s diabetic severity (Nathan et al., 2008; 
Goldstein et al., 2004). There are very few studies that explore the relationship between 
hemoglobin A1C and the increased risk for cholelithiasis (Al-Bayati & Kodayer, 2012). The 
findings of this study revealed gallstones were more prevalent in diabetic patients with increased 
hemoglobin A1C levels (Al-Bayati & Kodayer, 2012).  
The findings of this study were consistent with other established studies that 
cholelithiasis is a metabolic disease that is also linked to diabetes (De Santis et al., 1997; 
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Gielkens et al., 1998; Haffner, Diehl, Mitchell, Stern, & Hazuda, 1990; Shaw et al., 1993). This 
association with diabetes is further discussed in the comorbid conditions section (Please see page 
102).  
Liver Enzymes (ALT, AST, bilirubin) and Gallstones 
The literature describes liver cirrhosis as an independent risk factor for cholelithiasis, 
with a prevalence rate of 25% to 30% (Acalovschi, Badea, Dumitaccu, & Varga, 1988; Conte, 
Barisani, Mandelli et al., 1991; Conte, Fraquelli, Fornari et al., 1999). The most sensitive 
indicators to determine liver cell damage or disease are alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST). ALT and AST are the most common tests used to measure 
disease severity and hepatic activity (Kaplan, 2002; Tung et al., 2006), especially in patients with 
hepatitis C and liver cirrhosis (Sheth, Flamm, Gordon, & Chopra, 1998). In addition, serum 
bilirubin tests calculated in conjunction with ALT and AST have been used to identify types of 
liver diseases. This study did not find a significant association between serum liver enzymes and 
cholelithiasis occurrence in female veterans.  
Limited literature was found that identified the relationship between liver enzymes and an 
increased risk for cholelithiasis. Tung et al. (2006) described that elevated ALT levels may 
indicate an increased risk of cholelithiasis when type II diabetes is also present. This study 
suggests integrated diagnosis and therapeutic interventions in early liver cirrhosis may decrease 
the risk of cholelithiasis (Tung et al., 2006). However, literature was not found that supported 
liver enzymes as an independent risk factor associated with cholelithiasis. Grau et al.’s study 
(1999) demonstrated that elevation of ALT, AST, and bilirubin was unrelated to cholelithiasis 
occurrence but interpretation of biliary tract obstruction (Grau et al., 1999).  
Lipid Profile (total cholesterol, HDL, LDL, Triglycerides) and Gallstones 
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Significant differences were found in serum total cholesterol and HDL in female veterans 
with and without cholelithiasis. Female veterans with cholelithiasis had significantly higher total 
cholesterol values than those without cholelithiasis. Previous studies indicated that a high mean 
total cholesterol level was significantly associated with high prevalent cholesterol gallstone 
formation (Andreotti, 2008; Atamanalp et al., 2013; Khairy et al., 2004; Halldestam, Kullman, & 
Borch, 2009). However, some studies argued total cholesterol was inversely associated with 
cholelithiasis occurrence (Scragg, Calvert, & Oliver, 1984; Thijs, Knipschild, & Brombacher, 
1990). 
This study indicated that there was a significant association between low HDL 
cholesterol and an increased risk for cholelithiasis. Normal HDL cholesterol levels are 
considered to be over 60 mg/dL (National cholesterol education program, 2001). Although both 
groups with and without cholelithiasis had lower than normal HDL levels, the mean value was 
significantly lower in females with cholelithiasis (47.13 mg/dL) than those without cholelithiasis 
(56.28 mg/dL). Previous studies, based on randomized trials, have reported that patients with low 
HDL levels have a higher risk of developing cholesterol gallstones (Andreotti et al., 2008; Fu, 
Gong, & Shao, 1995; Tang, 1996; Thijs, Knipschild, & Brombacher, 1990). In contrast, some of 
the studies failed to find a relationship between low HDL levels and cholelithiasis occurrence 
(Aulakh, Mohan, Attri, Kaur, & Punia, 2007; Fu et al., 1997; Halldestam, Kullman, & Borch, 
2009). 
This study did not support a high serum LDL level as a strong indicator for increased risk 
of cholelithiasis (Fu, Gong, & Shao, 1995; Fu et al., 1997; Halldestam, Kullman, & Borch, 2009; 
Han, Jiang, Suo, & Zhang, 2000). Epidemiologic studies have indicated high serum levels of 
LDL were positively associated with increased risk for cholesterol gallstones (Fu, 1997; Han, 
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2000; Fu, 1995; Halldestam, 2009; Atamanalp, 2013); yet other studies found an inverse 
association between LDL and cholelithiasis occurrence (Andreotti et al., 2008; Tang, 1996). 
In this study, there was no significant correlation among serum triglyceride levels and 
cholelithiasis occurrence. Studies have reported hypertriglyceridemia observed in obesity, insulin 
resistance or excessive alcohol consumption have contributed to reduced bile salts, increased 
biliary cholesterol secretion, delayed gallbladder mortality, and crystal formations in the 
gallbladder (Jonkers et al., 2003; Lee, LaMonte, & Carey, 1981; Wang, Cohen, & Carey, 2009). 
Studies to identify the relation between high levels of triglyceride and increased risk for 
cholelithiasis were limited (Jonkers et al., 2003). 
Specific Aim 3 
Aim 3. Explore differences between diagnosed metabolic and biliary comorbidities experienced 
by female military veterans with and without cholelithiasis. 
The findings of this study indicated that cholelithiasis is closely related to metabolic 
disease. More female veterans with cholelithiasis had diabetes, dyslipidemia and hypertension 
and other comorbid diseases were associated with cholelithiasis occurrence. The prevalence of 
both hepatitis C and liver cirrhosis was also significantly higher in female veterans with 
cholelithiasis. A significant relationship was not found between hepatitis B and cholelithiasis 
occurrence in female veterans. PTSD and MST also had significant associations with 
cholelithiasis occurrences in female veterans.  
Metabolic Diseases and Gallstones 
Cholelithiasis is considered a metabolic disease because of its tight relationship with 
metabolic syndrome (Ata et al., 2011). Metabolic syndrome is a cluster of disorders that include 
abdominal obesity, high blood pressure, high fasting glucose, increased triglyceride levels and 
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low HDL cholesterol levels (Eckel, Grundy, & Zimmer, 2005; Mendez-Sanchez et al., 2005). 
Because metabolic syndromes include obesity, diabetes, hypertension, and dyslipidemia, the 
mechanism by which it causes gallstone formation is by increasing hepatic cholesterol secretion, 
reducing bile salt synthesis, and impairing gallbladder motility (Biddinger et al., 2008; Nakeeb, 
Comuzzi, Al-Azzawi, Sonnenberg, Kissebah, & Pitt, 2006). Although the relationship between 
diabetes mellitus and the risk for cholelithiasis still remains unclear, several studies have 
indicated that diabetes is a significant risk factor for cholelithiasis (De Santis et al., 1997; 
Gielkens et al., 1998; Haffner, Diehl, Mitchell, Stern, & Hazuda, 1990; Shaw et al., 1993). Ruhl 
and Everhart (2000) reported that patients with insulin-resistant type II diabetes have a 200-
300% increased risk for cholelithiasis over patients without diabetes. However, other population-
based studies have failed to find the relationship between diabetes and increased risk for 
cholelithiasis (Barbara et al., 1987; Jorgensen, 1989). This study supported a positive 
relationship among higher prevalence of diabetes and increased risk factors for cholelithiasis in 
female veterans.  
Although previous studies have indicated a relationship between individual serum 
cholesterol tests and cholelithiasis occurrence, the relationship between dyslipidemia and the risk 
for cholelithiasis remains inconclusive (Janzon, Aspelin, Eriksson, Hildell, Trell, & Ostberg, 
1985; Thijs, Knipschild, & van Engelshoven, 1990). Some studies have reported significant 
relationships among abnormal serum lipid levels and an increased risk of cholelithiasis 
(Andreotti, 2008; Atamanalp et al., 2013; Fu, Gong, & Shao, 1995; Khairy et al., 2004; 
Halldestam, Kullman, & Borch, 2009; Tang, 1996; Thijs, Knipschild, & Brombacher, 1990). 
However, other studies did not find the same associations (Andreotti et al., 2008; Aulakh, 
Mohan, Attri, Kaur, & Punia, 2007; Fu et al., 1997; Halldestam, Kullman, & Borch, 2009; Tang, 
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1996). The results of this study indicated dyslipidemia was significantly associated with 
cholelithiasis.  Female veterans with cholelithiasis had higher frequencies of dyslipidemia 
compared to those without dyslipidemia.  
Hypertension and Gallstones 
Hypertension is a component of metabolic disorder that could be considered to be 
reasonably association of cholelithiasis. It is unclear whether hypertension is an independent risk 
factor for cholelithiasis or what mechanisms related to high blood pressure are specifically 
associated with gallstone formation. Gaziano and associates (1993) have argued that patients 
who are overweight with increased diastolic pressure had a higher prevalence of cholelithiasis. 
Another study indicated that patients with blood pressures > 130/85 mmHg had a significantly 
higher risk of cholesterol gallstones (Thijs, Knipschild, & Brombacher, 1990). This study is 
consistent with previous studies indicating that female veterans with hypertension had a higher 
relationship with cholelithiasis. Even after controlling confounding variables, hypertension was 
one of the most significant risk factors for cholelithiasis occurrence in female veterans. This 
study showed that female veterans diagnosed with hypertension were 2.68 times more likely to 
develop cholelithiasis than those without hypertension.  
Biliary Diseases and Gallstones 
The literature has shown that there is a significant relationship between hepatitis C and 
liver cirrhosis and the increased risks for cholelithiasis (Acalovschi, Badea, Dumitaccu, & Varga, 
1988; Conte, Barisani et al., 1991; Conte et al., 1999) and the prevalence increases as liver 
disease progresses (Conte et al., 1991; Fornari, Civardi, Buscarini, Cavanna, 1990; Fornari, 
Imberti, Squillante, 1994). Previous studies have demonstrated that cholelithiasis was more 
prevalent in patients with hepatitis C virus (HCV) (11.7% - 23.3%) than in patients with hepatitis 
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B (Bini & McGready, 2005; Chang et al., 2005; Stroffolini, Sagnelli, Mele, Cottone, & Almasio, 
2007). An Italian study of patients with HCV related cirrhosis were two times more likely to 
have cholelithiasis in comparison to patients with hepatitis B related cirrhosis (Stroffolini, 
Sagnelli, Mele, Cottone, & Almasio, 2007). Another population-based study identified the 
increased risks for cholelithiasis occurred not only in men but also in women who were HCV 
positive (Acalovschi, Buzas, Radu, & Grigorescu, 2009).  
This study supported previous research that hepatitis C was significantly correlated with 
risk for cholelithiasis while no association was found in female veterans with hepatitis B. Some 
researchers explained the phenomenon associated with cholelithiasis that HCV infection may 
have contributed to abdominal adiposity and reduced bile salts, leading to insulin resistance 
(Acalovschi, Buzas, Radu, & Grigorescu, 2009, Cua, Hui, Kench, & George, 2008; Eguchi et al., 
2009) and increased bile cholesterol saturation (Acalovschi, Buzas, Radu, & Grigorescu, 2009).  
The results of this study were consistent in finding that liver cirrhosis has a high 
association with cholelithiasis. Additionally, liver cirrhosis in female veterans was significantly 
associated with cholelithiasis occurrence (Shaffer, 2006). Buchner and Sonnenberg (2002) study 
reported that the prevalence of gallstones was in 8% of patients with liver disease compared to 
5% of control patients without liver disease. The study also demonstrated that non-alcohol 
related liver cirrhosis was highly associated with increased risk for cholelithiasis as compared to 
alcohol-induced liver cirrhosis, which supported Volzke and associates’ study hypothesis that a 
moderate alcohol consumption may protect from gallstone formation. This study did not identify 
which type of liver cirrhosis was associated with cholelithiasis because it evaluated general risk 
factors related to cholelithiasis occurrence.  
85 
Liver cirrhosis has been established as a risk factor for cholelithiasis (Fornari et al., 1994; 
Olmo, Garcia, Serra, Maldonada, & Rodrigo, 1997). Studies have found the risk of cholelithiasis 
was approximately 8 times higher in patients with liver cirrhosis compared to the general 
population (Fornari et al., 1994; Olmo, Garcia, Serra, Maldonada, & Rodrigo, 1997). The overall 
prevalence rate for cholelithiasis was at 25-30% in patients with liver cirrhosis (Conte, Fraquelli, 
Fornari, Lodi, Bodini, & Buscarini, 1999; Conte et al., 1991; Zhang et al., 2006). It is believed 
liver cirrhosis may contribute to gallstone formation due to abnormal gallbladder motility, 
reduced hepatic synthesis, and decreased bile salts (Acalovschi, Badea, & Pascu, 1991; Alvaro, 
Angelico, Gandin, Ginanni, Corradini, & Capocaccia, 1990), leading to increase unconjugated 
bilirubin (Vitek & Carey, 2003). More than 80 percent of gallstones in liver cirrhosis are 
pigmented black stones (Diehl, Schwesinger, Holleman, Chapman, & Kurtin, 1995; Schwesinger 
Kurtin, Levine, & Page, 1985).  
Other Comorbid Conditions and Gallstones 
Posttraumatic stress disorder (PTSD). The finding of this study indicated female 
veterans with a diagnosis of PTSD had a higher risk of developing cholelithiasis than those 
without PTSD. No previous studies were found to support this study outcome. Because 
dyslipidemia is correlated with cholelithiasis, abnormal lipids values in female veterans with 
PTSD should be further evaluated. Karlovic et al. (2004) identified military veterans with 
combat-related PTSD had significantly higher levels of cholesterol, LDL, and triglyceride 
compared to veterans with combat experiences without PTSD and healthy control. This study 
also demonstrated serum HDL levels were significantly lower in veterans with combat-related 
PTSD than those without PTSD or in the healthy control group (Karlovic, Buljan, Martinac, & 
Marcinko, 2004). Another study also found that veterans with PTSD had significantly higher 
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cholesterol and lower HDL concentrations in comparison to other groups, such as Vietnam era 
veterans, substance abuse veterans, and civilians (Kagan, Leskin, Hass, Wilkins, & Foy, 1999).  
Although the etiology between high lipid levels and PTSD is unknown, it might be 
associated with military veterans’ diet patterns, stress levels, or activity levels.  
Military sexual trauma (MST). MST is a subcomponent of PTSD. It is defined by the 
US Department of Veterans Affairs as “sexual harassment that is threatening in character or 
physical assault of a sexual nature that occurred while the victim was in the military regardless of 
geographic location of the trauma, gender of the victim or the relationship to the perpetrator” 
(Veterans’ Benefits U. S. Code, Section, Title 38, 1720D, 1992) This study showed that the 
female veterans with cholelithiasis group reported higher rates of MST compared to females 
without cholelithiasis. Although the association with cholelithiasis was not significant when 
controlling for confounding factors, this result should be further evaluated. 
The literature indicated there is a broad range of negative health outcomes related to MST 
as well as sexual assault in civilian populations (Kimerling et al., 2007; Sadler et al., 2000; 
Skinner et al., 2000; Stein & Barrett- Connor, 2000). A recent study showed female veterans 
with diagnosed of MST have increased risks for anxiety, drug abuse, and higher rates of 
homelessness compared to female veterans without a history of MST (Decker et al., 2013). 
Another study reported that MST was an independent cause for decreased mental and cognitive 
functioning, quality of life, and somatic distress (Kimerling et al., 2007).  
The prevalence rate for MST in all eras of service ranges from 0.4% to 63.0% in women 
and 0.6% to 6.0% in men (Kang et al., 2005; Kimerling et al., 2010; Murdoch et al., 2014; 
Skinner et al., 2000; Suris & Lind, 2008; Wolfe et al., 1998). The wide range of prevalence is 
related to variability in sample collection. A study revealed a 0.4% prevalence rate with MST in 
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women from the Vietnam-era. Consequently, up to 63% of female veterans have sought 
treatment from a VHA stress disorder clinic (Fontana & Rosenheck, 1998). Studies with 
nationally collected samples have reported the numbers of military sexual trauma are more 
frequent in females and younger veterans (Kimerling et al., 2010; Suris & Lind, 2008). MST is 
also underreported (Department of Veterans Affairs, 2014), with a high suspicion that military 
sexual disorder is grossly underestimated in the females older than 40 years old.  
Specific Aim 4 
Aim 4. Explore associations among demographic, environmental, laboratory data and diagnosis 
of comorbid conditions among female military veterans with and without cholelithiasis.  
The findings of this study suggested several predisposing factors were independently 
associated with cholelithiasis occurrence in female veterans after controlling confounding 
effects. In this study, tobacco use was found be an independent risk factor for increased risk for 
cholelithiasis. The result also showed that female veterans who use tobacco had 3.15 times the 
risk of developing cholelithiasis compared to female veterans who did not use tobacco.  
This study’s results also revealed that higher hemoglobin A1C levels, higher total 
cholesterol levels, and lower HDL levels were independently associated with cholelithiasis 
occurrence. Female veterans with all three factors had a 26% likelihood to develop cholelithiasis.  
Although most comorbid conditions including diabetes, dyslipidemia, liver cirrhosis, 
hepatitis C, posttraumatic stress disorder, and military sexual trauma were highly related to 
female veterans with cholelithiasis, a significant correlation was not evident when controlling the 
confounding association between variables. However, hypertension and hepatitis C were 
identified as independent risk factors for cholelithiasis in female veterans. The result indicated 
that female veterans with a diagnosis of hypertension had 2.68 times the risk of developing 
88 
cholelithiasis compared to female veterans than without. Female veterans diagnosed with 
hepatitis C had 8.34 times the risk for developing cholelithiasis compared to female veterans 
without hepatitis. This result required a careful interpretation because of a wide range within the 
confidence interval (95% CI= 1.07-64.77).  
Methodological Consideration 
Many researchers believe daily-accumulated electrical medical records often referred to 
as ‘big data’ offers great promises for future research. This study is a big data study based on the 
corporate data warehouse of the VHA system. The approaches in systemic collecting and 
managing the big data were different from the traditional prospective research or retrospective 
data study based on chart reviews. This study demanded significant new training and education 
in order how to retrieve data from the corporate data warehouse as well as how to layout and 
store the retrieved data, to map and combine pieces of information tables, to comprehend how to 
filter data, to validate the retrieved cohort, and to analyze the final data in provided virtual setting 
in the Veterans Affairs Informatics and Computing Infrastructure (VINCI). The challenges of 
this study included learning all new terms, technologies, techniques, and institutional policies 
related to a big data study as well as managing interdisciplinary collaboration with a computer 
engineer, a data manager, data counselor, and data managing agencies. 
Despite challenges and difficulties in conducting a big data study, it was extremely 
valuable to be a part of this massive venture. Research based on the patients’ electronic medical 
data enhances medical practice and public health by investigating their real, accumulated, and 
objective information in an efficient and timely manner.  
Study Limitation 
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Although this study design was to determine the relationship between predisposing risk 
factors and cholelithiasis occurrence, some limitations may apply to this study. First, a major 
limitation was the potential selection bias when filtering data. The study cohort may not be 
representative of the general female veteran population. Second, missing or incorrect data, 
especially using retrospective data, might lead to bias due to invalid or imprecise study 
measurement. The researcher could not control for these errors but acknowledges them in the 
findings. Third, although this study only includes female veterans, no data was included such as 
parity, types of hormones, doses, or length of time on female hormone replacement therapy or 
contraceptives. Therefore, cholelithiasis occurrence in relation to female factors in this study 
could be underestimated. Fourth, serum laboratory levels were measured at a time when the 
disease was already present. Therefore, the strength of the relationship between abnormal serum 
laboratory levels and cholelithiasis occurrence could be underestimated.  
Implications for Nursing Science, Practice and Education 
The findings of this study provides several points that are especially pertinent to 
clinicians including nurses and physicians particularly in facilities that provide care to female 
veterans. Understanding prevalence and risk factors associated with cholelithiasis occurrence is 
essential for managing patient care and the prevention of gallstone formation (Broulik, Hass, & 
Adamek, 2005). Education to nurses and physicians may improve understanding of the 
physiological and scientific background knowledge of cholelithiasis occurrence, and that could 
serve as a resource when educating patients and patients’ family members. Identifying risk 
factors and prevention strategies related to cholelithiasis should be included in pre-licensure 
curricula so that nurses better understand the disease and can actively be involved in the 
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development of care plans specific to a patient with cholelithiasis or has possible risk factors for 
cholelithiasis.  
Additionally, the outcome of the study may contribute to building a strategic plan for 
preventing cholelithiasis. Due to multiple correlations with environmental factors, patient 
centered assessment of risk factors for cholelithiasis may be deployed to provide individual 
strategies to avoid symptomatic cholelithiasis and prevent the need for aggressive treatments or 
complications. The preventive program should not only include diagnosed disease control but 
also lifestyle modification aimed at optimizing dietary factors, physical activity and ceasing 
alcohol and tobacco consumption, especially among women. The outcome of this study may also 
be useful to guide practitioners towards choosing accurate diagnostic tests, especially in female 
veterans with unknown abdominal pain.  
Recommendations for Future Research 
Although the findings of this study identified that several risk factors were associated 
with increased risk for cholelithiasis occurrence in female veterans, they also raise additional 
questions that can be the basis for further research.  
 The findings of this study indicated that female veterans who used tobacco were at 
increased risk for cholelithiasis. There is a need to further evaluate the relationship 
between tobacco use and cholelithiasis occurrence while taking into consideration the 
types of tobacco used, tobacco frequency and the duration of the smoking habit. 
Other studies are also needed to investigate the impact of alcohol consumption on 
gallstone formation among female veterans. 
 Findings of this study revealed that high serum hemoglobin A1C levels were 
significantly associated with an increased risk of cholelithiasis. There is a need to 
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further examine levels of serum hemoglobin A1C over time and investigate whether 
the serum levels are associated with clinical symptoms in populations with 
cholelithiasis. It may be also worth determining whether advanced diabetics with 
controlled hemoglobin A1C have a higher risk for cholelithiasis.  
 Findings of this study identified that lipid levels were associated with an increased 
risk for cholelithiasis in female veterans. Although cholesterol is a primary 
contributing factor for cholesterol gallstone formation, the relationship among serum 
lipids level and an increased risk for cholelithiasis still remains unclear.  
Further studies are needed while taking into consideration the types, size, location, 
and onset of the gallstones in relation to cholelithiasis occurrence in female veterans. 
Findings of Jorgensen’s (1989) study identified that a newly developed small 
gallstone may contribute to abnormal serum lipids levels more than a large, slowly 
developing gallstone. In addition, there is a need to further evaluate the effects of 
lipid-lowering drugs on the occurrence of cholelithiasis in both women and veterans.  
 Findings of this study revealed that hypertension or hepatitis C were significantly 
associated with an increased risk cholelithiasis. There is a need to further investigate 
what physiological mechanism associated with high blood pressure leads to the 
increased risk for cholelithiasis. There is a need to further evaluate the relationship 
between controlled blood pressure and cholelithiasis occurrence in both women and 
veterans. Additionally, studies are needed to investigate whether chronic and acute 
hepatitis C are differently associated with cholelithiasis occurrence.  
 The female veteran population is estimated to increase by 12% within the next five 
years
 
while the male veteran population is projected to decrease by approximately 
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27% over the same period (Women Veteran Profile, 2013). Given the increase in 
female veterans serving longer military deployments and increases in warzone 
exposures, research should further explore factors that influence negative health 
outcomes in female veterans. Future studies are greatly needed to investigate the 
relationship between PTSD and increased risk for cholelithiasis occurrence in military 
female veterans. Considering the established relationship studies among dyslipidemia 
and increased risk factors for cholelithiasis, there is a need to further examine the 
degree of PTSD conditions associated with female veterans with symptomatic 
conditions on cholelithiasis. 
Overall Summary and Recommendation 
Cholelithiasis is one of the most common and expensive gastroenterological disorders 
and the prevalence has been rising, especially in women.  
This study identified tobacco use, high total cholesterol and hemoglobin A1C levels, low HDL 
levels and hypertension as independent risk factors for cholelithiasis occurrence in female 
veterans. Prior to this study, predisposing risk factors associated with cholelithiasis in female 
veterans had not been investigated although the VHA medical records indicated that the number 
of female veterans with cholelithiasis and needing cholecystectomy was clearly increasing within 
the  VHA system (VHA, 2014).  
The female veteran population will be experiencing high growth rate in the near future. 
The rising population is understudied and more research will allow health care providers to 
provide proactive strategies in predicting risk factors for cholelithiasis. Given that a large number 
of female veterans undergo surgical interventions, preventive strategies may decrease not only 
unnecessary surgeries but reduce surgical complications and improve quality of life.  
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